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Ischemic diseases, caused by the occlusion of a supplying blood vessel, result in a severe 
lack of oxygen and nutrients within the tissue. The ischemic insult triggers an inflammatory 
response of the innate immune system. Myeloid cells such as neutrophils and macrophages 
are recruited to the tissue to clear up debris and necrotic cells. In ischemia, adaptation to low 
oxygen levels is essential to cell survival. Prolyl-4-hydroxylase domain enzymes (PHD) 1, 2 
and 3 regulate the protein-stability of the α-subunit of hypoxia-inducible factor (HIF), which 
makes them the oxygen-sensors of the cells. In myeloid cells, PHD3 is a potent regulator of 
apoptosis in neutrophils and macrophages. PHD2 on the other hand affects macrophage 
metabolism and migration. The aim of this thesis was to further characterize the functions of 
PHD2 and 3 for macrophages in the context of ischemic diseases. 
I studied the role of PHD3 in myeloid cells upon induction of hind limb ischemia in a myeloid-
specific PHD3-/- mouse. After hind limb ischemia surgery, the infiltration of myeloid cells into 
the hind limb muscle as well as their clearance was analyzed via flow cytometry. The 
inflammatory response of PHD3-/- macrophages was blunted 4 and 5 days after surgery 
compared to wild type. Furthermore, the PHD3-/- macrophage population showed an 
increased surface expression of the anti-inflammatory marker CD206 4 and 5 days after 
surgery, indicating a faster initiation of wound healing compared to wild type. Despite the 
blunted macrophage response, perfusion recovery and angiogenesis were unaltered 
between PHD3-/- and wild type mice. However, the development of fibrosis was decreased in 
PHD3-/- mice 4 weeks after surgery, which could have been caused by the attenuated 
macrophage response. Neither a change in apoptosis nor in migratory behavior was 
observed in PHD3-/- macrophages which could serve as a possible explanation for the 
decreased inflammatory response of PHD3-/- macrophages. RNA sequencing of 
macrophages sorted from the hind limb 5 days after surgery revealed 10 differentially 
regulated genes. Cyp2s1, an epoxygenase which metabolizes Prostaglandin (PG) G2 and 
H2 to 12-hydroxyheptadecatrenoic acid (12-HHT), was significantly downregulated in PHD3-/- 
macrophages. This downregulation could be mimicked in bone marrow-derived 
macrophages (BMDM) when cultivated in starvation medium in hypoxia (1% O2). Under 
these conditions, BMDM also displayed a significantly higher secretion of PGE2, which might 
be explained by the downregulation of Cyp2s1. PGG2 and PGH2 are substrates for 12-HHT 
and PGE2 synthesis likewise. Lower Cyp2s1 expression could therefore leave more 





macrophages and therefore presents a putative explanation for the attenuated macrophage 
response in PHD3-/- mice. 
To study the role of PHD2 in macrophages in an ischemia model, I analyzed the effect of 
myocardial infarction in myeloid-specific PHD2-/- mice. Macrophage but not neutrophil 
invasion and clearance in the ischemic heart muscle were altered between wild type and 
PHD2-/- mice. Macrophage infiltration into the ischemic heart was delayed in PHD2-/- 
macrophages, which was linked to a worse heart function measured by echocardiography. In 
line with this, previous in vitro studies, conducted by another member of the Institute of 
Cardiovascular Physiology, found a migration defect in PHD2-/- BMDM as well as a lower 
phagocytotic capacity, which might account for the in vivo findings. These findings 
demonstrate non-redundant roles for PHD-isoforms PHD2 and PHD3 in myeloid cells. 
Myeloid-specific PHD2-deficiency presents a disadvantage in the resolution of ischemia-
induced inflammation while myeloid PHD3-deficiency leads to a faster resolution of 







1.1 Ischemic diseases 
Ischemic diseases present a serious and frequent health threat to modern society. 
Pathologic ischemia is most commonly caused by the occlusion of blood vessels which 
hinders the supply of oxygen and nutrients to the tissue of an organ or a whole extremity. 
Vessels can be either permanently or transiently closed. Both the acute lack of blood supply, 
as well as the reperfusion of the tissue, can cause severe damage, which leads to an 
inflammatory reaction by the innate immune system. In the long term, the loss of functional 
tissue by ischemia causes organ remodeling, which ultimately results in organ failure 
(reviewed by (Cohn et al., 2000)). Prominent examples for ischemic diseases are myocardial 
infarction (MI) or peripheral artery disease (PAD), both of them having a high prevalence 
worldwide. 
1.1.1 Myocardial infarction 
Myocardial infarction is a major cause of death worldwide. It is characterized by the 
ischemia-induced necrosis of heart tissue, which is caused by the occlusion of at least one 
coronary artery. Arteries occlude most commonly due to atherosclerotic plaques, but also 
due to vasospasms or endothelial dysfunction in less frequent cases (reviewed by (Thygesen 
et al., 2012)).  
Following the initial ischemic insult the myocardium undergoes several stages before a scar 
is formed. Within 2-4 hours after the ischemic event cells become necrotic. This is followed 
by an inflammatory reaction of the innate immune system and ultimately by the formation of a 
scar within 5-6 weeks after MI (reviewed by (Thygesen et al., 2012)). The resulting scar does 
not possess contractility, which impairs the heart muscle function. In turn, this leads to the 
remodeling of the heart. Cardiac remodeling takes the form of wall dilatation, hypertrophy or 
fibrosis and can ultimately lead to cardiac failure (reviewed by (Cohn et al., 2000)). The initial 
phases of tissue necrosis and the inflammatory response in the infarcted heart are important 
factors which influence the subsequent phase of cardiac remodeling and therefore the 
clinical outcome for each patient. A persistent inflammatory reaction, for example 
characterized by elevated serum monocyte chemoattractant protein (MCP)-1, correlates with 
reduced survival of the patients (de Lemos et al., 2007). However, the inflammatory reaction 
is also vital for the removal of cell debris. This is why therapeutic intervention should be well 






Current therapy aims at the fast restoration of the blood flow via locally administered 
fibrinolytica in combination with anticoagulants and antiplatelet therapy. On the long term, 
patients are treated with anti-hypertension and anti-thrombotic drugs, combined with a 
lifestyle intervention including cessation of smoking, weight control and more physical activity 
(reviewed by (Steg et al., 2012)).  
1.1.2 Peripheral artery disease (PAD) 
PAD has a high prevalence, affecting around 5% of 45-49 years-old worldwide. This number 
drastically increases with the age of the patients to around 20% in over 80-years old (Fowkes 
et al., 2013). PAD is characterized by the complete or partial occlusion of the superficial 
femoral artery. In less common cases the iliac, common femoral or tibiopereonal artery in the 
leg can be occluded by an atherosclerotic plaque. The occlusion of an artery leads to an 
ischemic state of the surrounding muscle tissue. This results in muscle fiber apoptosis and 
other morphological alterations of the muscle, including atrophy and muscle fiber 
denervation. These  phenomena are linked to increased levels of inflammatory mediators 
such as tumor necrosis factor (TNF)-α and interleukin (IL)-6 (Brevetti et al., 2010). 
The course of PAD can range from asymptomatic to chronic limb ischemia, the latter being 
connected to ischemic pain, ulceration of the extremity and leading to limb amputation in 
12% of the cases (reviewed by (Peach et al., 2012)). Clinical treatment focuses on treating 
symptoms and is only partially able to ameliorate the state of the patient. Examples include 
patients being advised to do more exercise or patients being pharmacologically treated with 
anti-platelet and vasodilatative therapeutics like cilostazol. In severe cases, surgical 
bypasses and stents are a frequent treatment method (reviewed by (Berger and Hiatt, 
2012)).  
More recently, gene therapies have been tested, which introduce pro-angiogenic genes via 
adenoviral or plasmid liposome transfer into the muscle tissue. Among the genes with 
promising clinical trial results are for example vascular endothelial growth factor (VEGF) and 
also hypoxia-inducible factor (HIF) (reviewed by (Berger and Hiatt, 2012)).  
1.2 Mechanisms that trigger sterile inflammation 
An inflammatory reaction, which is not induced by infectious pathogens such as bacteria or 
viruses, is called sterile inflammation. There are various triggers for a sterile inflammation 
such as irritant particles like asbestos or toxins, trauma, ischemia or ischemia reperfusion. 
These triggers cause cell death by necrosis. Necrotic cells are characterized by a permeable 
cell membrane and an uncontrolled release of cytoplasmic and organelle-associated 
molecules. Some intracellular molecules are under normal conditions not accessible to the 





leukocytes to the site. When for example healthy cell cytoplasm is injected into mice, 
components of this cytoplasm induce a sterile inflammation (Eigenbrod et al., 2008). 
Many intracellular components have been shown to act as inflammatory trigger. They have 
been termed pro-inflammatory damage-associated molecular membrane patterns (DAMPs). 
Among these DAMPs are for example the nuclear protein high-mobility group box 1 
(HMGB1), endogenous DNA, adenosine triphosphate (ATP) or mitochondrial compounds 
(Bours et al., 2006; Imaeda et al., 2009; Scaffidi et al., 2002; Zhang et al., 2010). In addition 
to that, cells can store inflammatory cytokines like IL-1α or IL-33 as active precursors inside 
the cell (Eigenbrod et al., 2008; Moussion et al., 2008). Upon uncontrolled membrane 
breakdown, these cytokines get released and can induce an inflammatory reaction. 
Extracellular proteins like hyaluronan act as DAMP when they are cleaved by intracellular 
proteases released by necrotic cells (Jiang et al., 2005). 
The pathways by which immune cells detect DAMPs and their respective contribution to the 
in vivo situation are not completely understood. Several proteins, such as HMGB1 and heat 
shock proteins (HSPs), are recognized by Toll-like receptors (TLRs) 2 and 4 (Quintana and 
Cohen, 2005; Vabulas et al., 2001; Yu et al., 2006). These receptors also play a major role in 
the recognition of pathogen-associated molecular membrane patterns (PAMPs) of viral or 
bacterial origin. TLR9 has been shown to not only recognize viral and bacterial DNA, but also 
endogenous DNA. TLR9 especially recognizes DNA from apoptotic cells or from 
mitochondria (Imaeda et al., 2009; Zhang et al., 2010). Other receptors, like the receptor for 
advanced glycation endproducts (RAGE) which recognizes S100 proteins, are unique to 
DAMP recognition (Hofmann et al., 1999).  
In addition, the NOD-, LRR-, and pyrin domain containing 3 (NLRP3) inflammasome can be 
activated by ATP or uric acid in order to stimulate secretion of active IL-1β (Kono et al., 2010; 
Mariathasan et al., 2006; Martinon et al., 2006). Upon activation, NLRP3 gets linked to pro-
caspase-1 via the adaptor protein apoptosis-associated speck-like protein containing a 
CARD (ASC). This process induces a self-cleavage of pro-caspase-1 into caspase-1, which 
can cleave inactive pro-IL-1β to IL-1β (reviewed by (Chen and Nunez, 2010). IL-1β is then 
released and induces neutrophil infiltration via its receptor IL-1R.  
Several other pathways and DAMPs have been implicated in the mediation of sterile 
inflammation. All of these pathways eventually lead to activation of tissue-resident 
macrophages and other tissue cells and recruitment of neutrophils and monocytes to the 





1.3 Cellular responses in sterile inflammation 
1.3.1 Macrophages 
Macrophages, first described by Elie Metchnikoff at the end of the 19th century, are very 
versatile cells (reviewed by (Gordon, 2007)). Under resting conditions, tissue macrophages 
act as sentinels. They home into different tissues, detect potential harm and attract other 
immune cells to the site to initiate an immunological response. In addition to that, they 
mediate organ homeostasis by phagocytosis of apoptotic cells. Together with dendritic cells, 
they are responsible for mediating peripheral tolerance in the lymph nodes. Along with B-
cells, dendritic cells and thymus epithelial cells they form the group of professional antigen-
presenting cells (APCs). Both intracellular and extracellular particles are being processed by 
professional APCs and presented on the cell surface via the proteins major histocompatibility 
complex (MHC) I and II to T-cells and B-cells (reviewed by (Roche and Furuta, 2015)). This 
allows for a close collaboration of the innate and adaptive immune system. Tissue 
macrophages develop already during embryogenesis. Several tissue-specific macrophage 
subtypes have evolved including for example Kupffer cells in the liver, microglia in the brain 
and osteoclasts in the bone (reviewed by (Epelman et al., 2014)).  
Macrophages detect danger signals, for example by TLRs as well as by phagocytosis of 
particles. This detection is mediated via complement, Fc and scavenger receptors (reviewed 
by (Gordon, 2007)). Upon detection of a danger signal, macrophages become activated and 
start to secrete cytokines and chemokines to fight pathogens and attract other immune cells. 
The diversity of potentially dangerous factors makes it necessary for the macrophage to have 
an equally diverse way to respond. Upon bacterial infection for example, macrophages can 
adopt a pro-inflammatory phenotype. This phenotype is effective at killing bacteria by 
increased nitric oxide (NO) and reactive oxygen species (ROS) production, as well as by 
secretion of pro-inflammatory cytokines like TNF-α, IL-1β and IL-6. In the environment of a 
tumor or during the resolution of inflammation, macrophages adopt a more anti-inflammatory 
phenotype. This phenotype is linked to increased secretion of IL-10 and increased 
phagocytosis of dead cells. Anti-inflammatory macrophages secrete pro-angiogenic factors 
like VEGF. They also produce transforming growth factor (TGF)-β, which stimulates the 
production of extracellular matrix (reviewed by (Murray and Wynn, 2011)).  
In cell culture, these pro- and anti-inflammatory phenotypes can be mimicked by 
administering specific cytokines. Interferon (IFN)-ɣ and lipopolysaccharide (LPS) induce 
naïve macrophages to polarize towards the classically activated (M1) pro-inflammatory 
macrophage type. LPS and IFN-ɣ mediate this activation via signal transducer and activator 
of transcription (STAT)1 and nuclear factor kappa-light-chain-enhancer of activated B cells 





(M2) anti-inflammatory state via STAT6 (reviewed by (Sica and Mantovani, 2012)). Various 
subtypes of M2-macrophages can be distinguished based on the different stimuli that induce 
them (Murray et al., 2014) or by their surface markers and secreted cytokines (reviewed by 
(Roszer, 2015)).  
1.3.2 Monocytes 
Monocytes are myeloid cells derived from the bone marrow that make up 5-10% of the 
nucleated cells in the blood stream. Two types of circulating monocytes can be distinguished: 
pro-inflammatory “classical” monocytes and patrolling monocytes. The patrolling monocytes 
migrate along the inside walls of vessels, where they most likely control the integrity of the 
endothelial layer. Inflammatory monocytes can be recruited to a site of inflammation, where 
they differentiate into pro-inflammatory macrophages or dendritic cells (reviewed by (Shi and 
Pamer, 2011)). In steady state however, their contribution to replenishing macrophage and 
dendritic cells in the tissue is limited (reviewed by (Ginhoux and Jung, 2014)).  
1.3.3 Neutrophils 
Neutrophils were first described as phagocytotic “microphages” by Elie Metchnikoff (reviewed 
by (Cavaillon, 2011)). Neutrophils are armed with many different antibacterial defense 
mechanisms. Like macrophages, they can generate NO and ROS to fight extracellular 
pathogens. They also store a wide range of proteolytic enzymes, like cathepsin G, and 
antimicrobial peptides, such as defensins (reviewed by (Geering et al., 2013)). These 
defense mechanisms are rather unspecific and can also cause much damage to healthy 
tissue when they get released. This is why neutrophil lifespan and localization are tightly 
controlled. 
Neutrophils are differentiated in the bone marrow from myeloid progenitors. Their 
differentiation is regulated by the granulocyte colony-stimulating factor (G-CSF) (reviewed by 
(Demetri and Griffin, 1991)). In resting conditions, mature neutrophils are released into the 
blood stream where they have a restricted lifespan of 1 to 5 days (Pillay et al., 2010). As they 
are a potential threat to tissue cells, neutrophils do not migrate into healthy tissues. At the 
end of their short lifespan, senescent neutrophils are removed in spleen, liver and in the 
bone marrow (reviewed by (Furze and Rankin, 2008)). A pool of mature neutrophils is kept in 
the bone marrow and is constantly replenished. This allows for a very fast response during 
the initiation of inflammation. 
1.3.4 Neutrophil, monocyte and macrophage interplay in sterile inflammation 
A sterile inflammation such as ischemia-induced injury is initiated when DAMPs get 
recognized by tissue macrophages. Via binding to receptors such as IL-1R, TLRs and 
RAGE, macrophages get activated and secrete inflammatory mediators like chemokine (C-X-





CXCL1 gradients in the blood attract neutrophils which migrate into the tissue (reviewed by 
(Silva, 2010). Neutrophils are rapidly recruited from the blood and from the bone marrow. 
They arrive in the injured tissue within hours, which makes them the first wave of 
inflammatory cells migrating to the place of injury. 
Activated endothelial cells and macrophages secrete chemokines like C-C chemokine ligand 
(CCL) 2, which attracts monocytes and mediates adhesion and migration of pro-inflammatory 
“classical” monocytes into the tissue. In addition, neutrophils release granules while they 
extravasate through the endothelial layer into the tissue. These granules contain for example 
cathepsin G and azurodicin, which are potent monocyte attractants. The invading monocytes 
differentiate into pro-inflammatory macrophages and dendritic cells upon migration into the 
tissue and, together with neutrophils and activated tissue macrophages, mediate the early 
phase of inflammation (reviewed by (Soehnlein and Lindbom, 2010)). In addition to the 
monocyte-derived macrophages, there is evidence that tissue macrophages can also 
proliferate locally upon induction of inflammation (Robbins et al., 2013). 
The interaction of the different immune cells with each other and with their environment is 
vital for the time course of inflammation. The restricted lifespan of neutrophils is prolonged by 
macrophage-derived pro-inflammatory cytokines such as TNF-α, IL-1β, G-CSF and 
granulocyte macrophage colony-stimulating factor (GM-CSF). Additionally, hypoxia, which is 
a common condition in inflamed loci, increases neutrophil lifespan and regulates the 
inflammatory response of macrophages (Cramer et al., 2003; Walmsley et al., 2005). To 
ultimately limit neutrophil recruitment to the tissue, macrophages secrete prostaglandins 
(PG) E2 and D2. PGE2 and PGD2 stimulate the synthesis of anti-inflammatory mediators 
such as lipoxins which inhibit neutrophil infiltration while promoting monocyte migration.  
The resolution of inflammation is initiated by the phagocytosis of apoptotic neutrophils by 
macrophages. Apoptotic neutrophils release anti-inflammatory mediators such as Annexin 
A1. Also, they upregulate “find me” signals like sphingosine-1-phosphate to attract 
macrophages which phagocytose the dying neutrophils (reviewed by (Ravichandran, 2010)). 
The phagocytosis of dead cells, also called efferocytosis, primes macrophages to a more 
anti-inflammatory (M2) phenotype.  
In the following restoration of tissue homeostasis, macrophages secrete VEGF to enhance 
angiogenesis as well as immunosuppressive factors like IL-10. In addition, macrophages 
produce TGF-β which activates fibroblasts and enhances their secretion of extracellular 
matrix components. Fibrotic tissue forms a scar to replace the functional tissue which has 
been lost due to the original trigger of injury and to the ensuing inflammatory reaction 






Molecular oxygen is needed for aerobic metabolism, which provides the foundation for the 
life of most complex organisms. The human body takes up oxygen from the air via the 
alveolae in the lung. Oxygen then gets distributed via the blood stream and reaches the 
different tissues via diffusion. Physiological partial oxygen pressures (pO2) within the cells 
can vary depending on the organ and typically lie between 25-65 mm Hg (Vaupel et al., 
1989). Hypoxia occurs when the pO2 drops below the physiological level of the respective 
tissue, causing an imbalance between oxygen supply and consumption within the cells.  
Both physiological and pathological conditions can trigger hypoxia. Being at high altitudes for 
example, where the pO2 is lower than at sea level, presents a physiological trigger for 
hypoxia. During parts of embryogenesis, hypoxia is vital for the correct formation of organs 
and blood vessels, with differentiation of progenitor cells being in part mediated by oxygen 
levels (reviewed by (Simon and Keith, 2008)). In pathological settings, hypoxia occurs most 
frequently by insufficient blood flow to a tissue, which results in ischemic diseases such as 
MI. Hypoxia can also occur in inflamed lesions by the massive infiltration of oxygen-
consuming immune cells or when a tumor outgrows its blood supply.  
Hypoxia, especially in pathologic conditions, can present a major challenge for the cells in a 
tissue as they highly depend on it to mobilize energy: many cells metabolize nutrients 
predominantly via the oxygen-dependent oxidative phosphorylation. This reaction generates 
ATP, which is needed for every energy-consuming reaction happening in a cell. When 
oxygen is no longer available at sufficient levels, cells either undergo cell death or they adapt 
to hypoxia. Adaptation to hypoxia includes short term effects, like the shift of metabolism 
towards anaerobic glycolysis, as well as long term adaptation via induction of erythropoiesis 
and angiogenesis. Most of these adaptations are regulated by the transcriptional regulation 
of the respective enzymes or growth factors. The hypoxia-inducible factors (HIFs), a 
transcription factor family, present the key mechanism to this hypoxic adaptation.  
1.4.1 Hypoxia-inducible factors 
HIFs were first described as proteins binding to the enhancer of the EPO gene in a hypoxia-
inducible manner (Semenza and Wang, 1992). HIFs comprise a small family of heterodimeric 
transcription factors, which are composed of a hypoxia-regulated HIFα subunit and HIF-1β 
which is present at constant levels (Wang et al., 1995; Wang and Semenza, 1995). HIF-1β 
had already been described as aryl hydrocarbon receptor nuclear translocator (ARNT) 
before, a protein which can interact with aryl hydrocarbon receptor (AHR) in order to function 
as a receptor for dioxins and polycyclic aromatic hydrocarbons (Hoffman et al., 1991). Both 
HIFα and HIF-1β are basic-helix-loop-helix (bHLH) proteins containing Per-ARNT-Sim (PAS) 





The group of HIFα proteins that can interact with HIF-1β are comprised of HIF-1α, HIF-2α 
and HIF-3α. HIF-1α and HIF-2α show a similar protein structure, with bHLH and PAS 
domains at the N-terminus. They also include an oxygen-dependent degradation (ODD) 
domain, as well as two transactivation domains (N-TAD and C-TAD) for transcriptional 
activity (Figure 1) (Jiang et al., 1997; Pugh et al., 1997). HIF-1α and HIF-2α have a common, 
but not completely overlapping, set of target genes indicating their synergistic function.  
 
Figure 1: Protein structure of HIF-1α and HIF-1β including domains and modification sites. HIF-
1α and HIF-1β both possess a basic helix-loop-helix (bHLH) and a Per-ARNT-Sim (PAS) domain for 
interaction with DNA and with each other respectively. HIF-1α possesses an oxygen-dependent 
degradation (ODD) domain containing an N-terminal transactivation domain (N-TAD). The ODD 
domain includes two conserved prolines (P402 and P564), which can be hydroxylated by prolyl-4-
hydroxylase domain enzymes. HIF-1α also possesses a C-terminal transactivation domain (C-TAD) 
with a conserved asparagine (N803), which can be hydroxylated by Factor Inhibiting HIF-1.  
There are multiple variants described for HIF-3α. Full length HIF-3α includes bHLH and PAS 
domains, an ODD domain as well as a N-TAD, but not a C-TAD domain. Full length HIF-3α is 
described to have only limited function in the hypoxia response, which is typically mediated 
by HIF-1α and -2α (Gu et al., 1998). Shorter variants of HIF-3α, such as the inhibitory PAS 
domain protein (IPAS), have been described to dimerize with HIFα subunits, thereby 
inhibiting their ability to act as a transcription factor (Makino et al., 2002). 
1.4.2 HIF-target genes 
Together with HIF-1β, HIFα subunits bind to hypoxia-responsive elements (HREs) in or 
outside promoter regions of its target genes. Those HREs consist of the sequence 
(A/G)CGTG, with the most abundant form being ACGTG (reviewed by (Wenger et al., 
2005)).  
The onset of hypoxia forces the cell to change its metabolism towards anaerobic glycolysis. 
For this adaptation HIF-regulated gene expression of glucose transporters (GLUT)1 and 3 
increases in order to transport more glucose into the cells (Chen et al., 2001). Furthermore, 
several metabolic enzymes are HIF-target genes. These include for example Pyruvate 
dehydrogenase lipoamide kinase isoenzyme 1 (PDK-1), which inhibits the tricarboxylic acid 
(TCA) cycle by inhibition of pyruvate dehydrogenase (PDH). PDH is an enzyme that converts 
pyruvate to acetyl-CoA (Kim et al., 2006; Papandreou et al., 2006) which is then fed into the 





has been shown to act as a coactivator of HIF, which promotes its transcriptional activity 
(Luo et al., 2011). 
An important HIF-1α target gene, especially in myeloid cells, is the inducible NO synthase 
(iNOS) which produces NO as a defense mechanism against invading pathogens (Fang, 
1997; Melillo et al., 1995; Melillo et al., 1997)). Interestingly, HIF-2α induces the expression 
of arginase-1, which converts L-arginine into ornithine and urea (Takeda et al., 2010). L-
arginine is also needed for NO production by iNOS, which puts both enzymes in direct 
competition for their substrate. Anti-inflammatory macrophage polarization has been shown 
to correlate with increased levels of HIF-2α, while HIF-1α mediated iNOS induction primed 
macrophages to a pro-inflammatory phenotype (Takeda et al., 2010). HIF-1α and -2α have 
been shown to differ in their time course of protein stabilization upon induction of hypoxia. 
While HIF-1α is transiently stabilized in the early hypoxic phase, HIF-2α stabilization is also 
prominent in prolonged hypoxia (Holmquist-Mengelbier et al., 2006; Kong et al., 2007). This 
might indicate different roles for HIF-1α and HIF-2α for the different phases of macrophage 
activation during tissue hypoxia- with HIF-1α promoting the early inflammatory and HIF-2α 
mediating the subsequent regulatory and anti-inflammatory phase. 
In hypoxia, cell survival and apoptosis need to be regulated in order to prevent cell necrosis 
and subsequent damage to the tissue. Certain factors influencing cell survival are HIF-target 
genes. An example of such a factor is  BCL2/adenovirus E1B 19 kDa protein-interacting 
protein 3 (Bnip3), which mediates mitophagy (Band et al., 2009; Tracy et al., 2007). A 
connection between HIF and p53 signaling has furthermore been established by various 
researchers (reviewed by (Obacz et al., 2013). The anti-apoptotic factor B cell lymphoma-
extra large (Bcl-XL) is also a direct HIF-target gene (Chen et al., 2009). 
To overcome long term hypoxia, endothelial cell growth is stimulated to restore blood flow via 
angiogenesis.  VEGF which is a potent pro-angiogenic factor is upregulated as a HIF-target 
gene (Connolly et al., 1989; Shweiki et al., 1992). Additionally, erythropoiesis is stimulated by 
the upregulation of EPO, which was the first described HIF-target gene (Semenza and 
Wang, 1992). 
Overall, more than 100 target genes of the hypoxia-inducible factors have been described 
that play an important role in the adaptation to hypoxia. 
1.4.3 Hypoxia-inducible factor-1 regulation 
While HIF-1β is stably expressed in normoxia and hypoxia, HIFα protein levels are highly 
dependent on the availability of oxygen. In normoxia, HIF-1α is only present at basal levels 





HIF-1α is again diminished to basal levels within minutes (Huang et al., 1998; Moroz et al., 
2009).  
The fast kinetics of HIF-1α protein levels suggest a regulation mechanism which is not 
mediated on a transcriptional level. Indeed, levels of HIFα subunits are mainly regulated via 
their protein stability. In normoxia these subunits are recognized by the von-Hippel Lindau 
tumor suppressor protein (pVHL), which is a component of an Ubiquitin E3 ligase complex 
(Maxwell et al., 1999). Following the recognition by pVHL, HIFα is ubiquitinated which leads 
to its proteasomal degradation.  
pVHL can only effectively bind HIFα when conserved proline residues (HIF-1α: Pro 402 and 
Pro 564) in the ODD domain of HIFα are hydroxylated (Figure 1). This hydroxylation is 
mediated by Prolyl-4-hydroxylase domain enzymes (PHD) 1, 2 and 3 (Ivan et al., 2001; 
Jaakkola et al., 2001). PHDs need cofactors like 2-oxoglutarate (2-OG), Fe2+, ascorbate and 
most importantly molecular oxygen for their enzymatic activity. Therefore, HIFα is rapidly 
degraded when enough oxygen is available. In hypoxia however, hydroxylation of HIFα by 
the PHDs is inhibited, and HIFα is no longer recognized by pVHL. HIFα gets stabilized and 
can then translocate into the nucleus and dimerize with the stably expressed HIF-1β to 
activate the expression of its target genes (Figure 2).  
 
Figure 2: Overview of the oxygen-dependent degradation of HIF-1α by prolyl-4-hydroxylase 
domain enzymes (PHDs). HIF-1α is hydroxylated by PHDs which need the cofactors Fe(II), oxygen 
and 2-oxoglutarate (2-OG) for their enzymatic activity. The hydroxylated HIF-1α is recognized by von-





1α and subsequent proteasomal degradation. When oxygen is not present at sufficient levels, HIF-1α 
is stabilized, translocates into the nucleus, dimerizes with HIF-1β and activates transcription of its 
target genes, including vascular endothelial growth factor (VEGF), erythropoietin (EPO) and glucose 
transporter 1 (GLUT-1), via binding to hypoxia-responsive elements (HREs) in their enhancers or 
promoters. 
PHDs are not the only enzymes that can modify HIFα proteins. Factor inhibiting HIF (FIH)-1 
is an asparaginyl hydroxylase enzyme, which hydroxylates a conserved asparagine residue 
(HIF-1α: Asn 803, HIF-2α: Asn 851) in the C-TAD region of HIFα (Lando et al., 2002a). This 
modification has been reported to inhibit HIFα association with CREB-binding protein and 
p300 (Lando et al., 2002b), which act as coactivators of HIF-mediated transcription (Kallio et 
al., 1998; Ruas et al., 2010). Similar to the PHDs, FIH-1 needs molecular oxygen to convey 
hydroxylation of the conserved asparagine residue. As a result, this asparagine is constantly 
hydroxylated in normoxia, leading to an inhibition of HIF. In hypoxia, hydroxylation can no 
longer take place, which leads to transactivation of gene expression. FIH-1 has furthermore 
been demonstrated to form a complex with HIF-1α and pVHL, which inhibits HIFs activity as 
a transcription factor (Mahon et al., 2001). 
1.4.4 PHDs 
PHD enzymes belong to a group of 2-OG-dependent dioxygenases which catalyze the 
hydroxylation of conserved prolines within the structure of HIF-α subunits as well as of 
several other proteins. PHD 1, 2 and 3 have a 42-59% structural similarity to each other 
(Hirsila et al., 2003) while P4H-TM, the fourth member of this enzyme family, is structurally 
quite different (Koivunen et al., 2007; Oehme et al., 2002). Their function as prolyl-4-
hydroxylases, as well as their binding sites for Fe(II) and 2-OG are however highly 
conserved. Other prolyl-4-hydroxylases (P4H), like the collagen-P4H (c-P4H) enzymes utilize 
the same cofactors as PHDs (Hutton et al., 1966). The essential difference between those 
enzymes and the PHDs is the binding affinity for oxygen. PHDs all bind oxygen with a Km-
value of 230-250 µM, which is slightly above the concentration of dissolved O2 at 
atmospheric conditions (Hirsila et al., 2003). This high Km-value is a prerequisite for the 
oxygen sensor function of PHDs because it results in oxygen being the limiting factor, while 
c-P4H enzymes still work efficiently at low oxygen concentrations.  
1.4.4.1 Proline-4-hydroxylation of HIF 
PHD enzymes mediate the trans-4-hydroxylation of conserved prolines within the structure of 
HIFα subunits. The conserved prolines that are hydroxylated by PHDs lie in a LXXLAP amino 
acid motif, which is conserved (Epstein et al., 2001). However, HIFα hydroxylation can also 
take place when single amino acids are replaced (Huang et al., 2002; Li et al., 2004). Out of 
those two prolines, Pro564 (HIF-1α) is hydroxylated first. This prior hydroxylation of Pro564 





In order to mediate proline-4-hydroxylation, PHDs need the cofactors Fe(II), ascorbate, 
molecular oxygen and 2-OG. Fe(II) is very important for the coordinated binding of the 
substrates HIF, 2-OG and oxygen. Binding to Fe(II) allows oxygen to attack one ketone 
group of 2-OG. 2-OG is decarboxylated which results in the formation of succinate and CO2 
and requires one oxygen atom from the O2 molecule (Figure 3). The remaining oxygen atom 
is bound in a highly active oxo-ferryl intermediate. This intermediate captures one hydrogen 
atom from proline to then introduce a hydroxyl radical back to form 4-hydroxyproline 
(reviewed by (Berra et al., 2006; Smirnova et al., 2012)).  
 
Figure 3: Prolyl-4-hydroxylation reaction. The substrate 2-oxoglutarate (2-OG) is decarboxylated by 
the Fe(II)-bound oxygen. This results in the formation of succinate and CO2, which incorporates one 
oxygen atom of the oxygen molecule. The other oxygen atom gets integrated into proline forming a 
hydroxyl group at position C-4.  
1.4.4.2 Differences between PHD isoform expression patterns  
PHD1, 2, 3 and P4H-TM have distinct expression patterns within the cell. PHD1 is 
predominantly located in the nucleus (Metzen et al., 2003). The transport of PHD1 into the 
nucleus is mediated via a nuclear localization sequence (NLS) in a α/β-importin-dependent 
manner (Steinhoff et al., 2009). In contrast to that, PHD2 is actively transported out of the 
nucleus via a nuclear export sequence (NES) and is mostly present in the cytoplasm (Metzen 
et al., 2003; Steinhoff et al., 2009). PHD3 is localized both in the cytosol and the nucleus 
(Metzen et al., 2003). 
In contrast to PHD1, 2 and 3, P4H-TM (called PH4 by (Oehme et al., 2002)) has a 
transmembrane domain and is localized in the endoplasmatic reticulum (ER) facing its lumen 
(Koivunen et al., 2007; Oehme et al., 2002). Despite this location, P4H-TM overexpression or 
knock down still have an influence on HIF-1α levels in cellulo and on EPO levels in vivo 





(Koivunen et al., 2007). It however remains unknown how P4H-TM exhibits those effects 
from inside the ER-lumen.  
PHD2 is the most abundantly expressed isoform in different organs and cell types compared 
to the other PHDs (Appelhoff et al., 2004). In contrast to that, both PHD1 and PHD3 are 
widely expressed at low levels, but show high expression levels only in a few distinct tissues. 
While PHD1 is highly expressed in hormone-responsive tissues and is the only PHD present 
in the testis, PHD3 is highly present in the adult heart and brain, as well as in various 
embryonic tissues (Lieb et al., 2002). The clear differences in expression pattern both 
intracellular and between different tissues already hints at non-redundant functions of the 
three isoforms. 
1.4.4.3 Different roles of the PHDs in the hydroxylation of HIFα  
PHD1, 2 and 3 differ distinctly from each other in their role for HIFα stabilization. PHD2 is the 
most abundantly expressed isoform and has a dominant role in regulating HIFα protein 
stability in normoxia (Appelhoff et al., 2004; Berra et al., 2003). PHD3 is a HIF-target gene 
which gets highly induced in hypoxia, presumably as part of a negative feedback loop (del 
Peso et al., 2003; Pescador et al., 2005). Indeed, PHD3 retains more of its enzymatic activity 
in hypoxia than PHD1 and 2, which makes it a potent regulator of HIF-1α in hypoxia 
(Appelhoff et al., 2004; Ginouves et al., 2008). PHD2 is also a HIF-target gene and 
moderately induced in hypoxia, while PHD1 is not upregulated in hypoxia or in some cell 
lines even downregulated (Appelhoff et al., 2004; Berra et al., 2003; Epstein et al., 2001; 
Metzen et al., 2005). Instead, transcription of PHD1 is induced by the estrogen-receptor in 
hormone-sensitive cells (Seth et al., 2002). 
It is furthermore suggested that PHD2 targets preferentially HIF-1α while PHD3 shows a 
stronger activity towards HIF-2α (Appelhoff et al., 2004). PHD2 and 3 show an equally high 
activity for hydroxylation of HIF-1, 2 and 3α in pVHL capture assays, while PHD1 activity is 
significantly lower (Tuckerman et al., 2004). Also, the activity of the three PHDs towards the 
two conserved prolines is different. PHD3 is almost incapable of hydroxylating Pro402 on 
HIF-1α, while PHD1 and 2 are both capable of doing so (Hirsila et al., 2003). Furthermore, 
PHD3 seems to identify Pro564 by the amino acid sequence in the immediate proximity, 
while PHD1 and 2 both recognize it by its general location (Chan et al., 2005). 
1.4.4.4 PHD1 
PHD1 homozygous knock out mice are viable and do not show any obvious phenotypes. 
Upon induction of hind limb ischemia, myofibers from PHD1-/- mice are protected from lethal 
damage by a metabolic shift towards anaerobic glycolysis (Aragones et al., 2008). This 





ischemia-reperfusion damage (Schneider et al., 2010) and in a stroke model (Quaegebeur et 
al., 2016).  
Apart from HIFα, PHD1 can also hydroxylate other substrates. Hypoxia-mediated induction of 
NF-κB signaling has been shown to be mediated by PHD1. PHD1 hydroxylates a proline in 
an LXXLAP sequence of IKKβ (Cummins et al., 2006). In addition to its influence on NF-κB 
signaling, PHD1 also influences inflammation in vivo. In a model of inflammatory bowel 
disease, PHD1-/- mice had a better survival rate than wild type littermates, which was 
mediated by an enhanced endothelial barrier function and decreased enterocyte apoptosis 
(Tambuwala et al., 2010). Also, human biopsies of ulcerative colitis were found to have 
increased PHD1 RNA and protein levels, which correlated with increased pro-inflammatory 
TNFα and IL-8 levels (Van Welden et al., 2013). 
1.4.4.5 PHD2 
PHD2 seems to have a vital role for physiological processes, especially in the cardiovascular 
system. Homozygous deletion of PHD2 leads to embryonically lethal defects in heart and 
placenta formation of mice (Takeda et al., 2006). In contrast to that, heterozygous PHD2 
knock out mice (PHD2+/-), in which PHD2 RNA levels are decreased by half, are viable 
without any gross defects (Mazzone et al., 2009). Mice in which a homozygous PHD2 knock 
out is induced after early embryogenesis develop polycythemia and dilated cardiomyopathy 
with a drastically decreased life span (Minamishima et al., 2008). In humans, loss-of-function 
mutations of PHD2 have been described to lead to a form of familial erythrocytosis (Percy et 
al., 2007; Percy et al., 2006). 
PHD2 plays an important role in vessel formation and maintenance. Conditional PHD2-/- 
knock out mice showed altered vessel morphology and erythema (Takeda et al., 2006). In 
cell culture, endothelial cell proliferation was inhibited by overexpression of PHD2, which was 
mediated independently of PHD2´s hydroxylase activity (Takeda and Fong, 2007). In the 
context of tumor metastasis, injection of tumor cells into PHD2+/- mice led to better 
oxygenated tumors and vessels showed less angiogenesis and an improved endothelial 
barrier (Mazzone et al., 2009). The normalization of the vessels might have led to the drastic 
decrease in metastasis formation that was observed. 
In myeloid-specific PHD2 knock out mouse models, the lack of PHD2 led to decreased pro-
inflammatory cytokine expression (Ikeda et al., 2013; Mamlouk et al., 2014). Expression of 
anti-inflammatory cytokines was unchanged or slightly downregulated in PHD2-deficient 
macrophages. In a model of increased afterload, this effect correlated with reduced cardiac 
hypertrophy and fibrosis. Tissue sections of these hearts showed decreased invasion of 





tumor model, decreased cytokine levels correlated with a decrease in tumor growth, which 
originated from both increased proliferation and cell death rates (Mamlouk et al., 2014). 
The function of PHD2 in myeloid cells has also been studied in mice with a global PHD2 
haplodeficieny. In a model of hind limb ischemia, downregulation of PHD2 mRNA expression 
by 50% led to a M2-like polarization of macrophages, which stimulated smooth muscle cells 
and thereby improved arteriogenesis (Takeda et al., 2011). This effect could not be seen in a 
homozygous myeloid-speciic PHD2 knock out. Furthermore, upon induction of hind limb 
ischemia in wild type mice, PHD2 levels in macrophages were shown to be decreased by 
half by the action of angiopoietin-1, which in a feed-forward loop led to induction of TIE2, the 
angiopoietin-receptor (Hamm et al., 2013). 
1.4.4.6 PHD3 
Besides HIFα, PHD3 can also mediate the stability of other proteins. These proteins include 
for example activating transcription factor 4 (ATF-4), β-adrenergic receptor, non-muscle actin 
and PKM2 (Koditz et al., 2007; Luo et al., 2011; Luo et al., 2014; Xie et al., 2009). A recent 
publication employed a substrate trap mediated by dimethyloxaloylglycine (DMOG), 
combined with a mass spectrometry approach, to identify more substrates of PHD3. In total, 
388 putative PHD3 substrates were identified, of which many still need to be confirmed by 
independent methods (Rodriguez et al., 2016).  
A global murine knock out of PHD3 produces viable PHD3-/- offspring, which show a 
sympathetic dysfunction. This resulted in decreased blood pressure and hypersensitivity to 
adrenergic agonists (Bishop et al., 2008). 
The role of PHD3 in myeloid cells is only partially understood. The above mentioned global 
PHD3 knock out showed an increased lethality when challenged with LPS in a model of 
abdominal sepsis. This was linked to increased macrophage infiltration into different organs 
and with higher plasma cytokine levels. The authors referred this to a pro-inflammatory 
polarization of the macrophages as a result of increased NF-κB signaling due to HIF-1α 
stabilization (Kiss et al., 2012). In a myeloid-specific PHD3 knock out, however, no pro-
inflammatory polarization could be observed in fully differentiated bone marrow-derived 
macrophages (BMDM) (Swain et al., 2014). Instead, PHD3-/- BMDM showed an increased 
differentiation rate, which most likely also caused the higher cytokine expression observed by 
Kiss and colleagues in not fully differentiated macrophages. Additionally, PHD3-/- 
macrophages were protected against apoptosis in stress conditions, such as starvation. In 
neutrophils, PHD3 deficiency led to enhanced apoptosis selectively in hypoxia by 
upregulation of the pro-apoptotic Siva1 (Walmsley et al., 2011). There are furthermore 
reports that observe an inhibitory effect of PHD3 on NF-κB signaling (Fu and Taubman, 





however, no regulation of NF-κB signaling could be observed in basal conditions, while NF-
κB activity was decreased in PHD3-deficient BMDM upon stimulation with LPS (Swain et al., 
2014). The effect of PHD3-/- macrophages on sterile inflammation has not been studied so 
far. 
1.5 Aim of the thesis 
Ischemic diseases such as peripheral artery disease and myocardial infarction are 
characterized by a hypoxic and ischemic insult to the muscle tissue. This then leads to 
necrosis, followed by a sterile inflammation. Innate immune cells, such as macrophages and 
neutrophils, are vital for the clearance of cell debris and the initiation of wound healing. 
However, prolonged inflammation can have detrimental effects on organ function.  
HIFs, which mediate the response of cells towards hypoxia, also regulate properties of 
myeloid cells like macrophage polarization into pro- or anti-inflammatory types and neutrophil 
survival. HIFs are tightly regulated on protein level by proteasomal degradation, which is 
dependent on hydroxylation mediated by PHD 1, 2 and 3. PHD enzymes utilize molecular 
oxygen for the hydroxylation of HIF, which makes them the oxygen sensors of the cell. Their 
role for myeloid cells such as macrophages is only partially understood.  
PHD3 has been demonstrated to be a pro-apoptotic factor in macrophages, while in an 
infectious inflammation model, lack of PHD3 led to an increased inflammation. In the setting 
of a sterile inflammation however, no data about the specific role for PHD3 in macrophages 
have been reported so far. The aim of the thesis was therefore to study the role of PHD3 for 
the tissue response to ischemia in a myeloid-specific PHD3 knock out model in vivo via the 
surgical induction of hind limb ischemia. The following questions were addressed: 
1. Does a myeloid-specific PHD3 knock out alter the course of inflammation after hind 
limb ischemia?  
2. How does a myeloid-specific PHD3 knock out influence clinical parameters such as 
reperfusion recovery, angiogenesis, motor function and fibrosis after hind limb 
ischemia? 
3. Are alterations in the course of inflammation based on an altered macrophage 
functions, such as polarization, apoptosis or migration capacity? 
4. How do PHD3-/- macrophages after hind limb ischemia differ from wild type cells in 
their RNA expression? 
5. Can the differentially regulated genes alter macrophage behavior? 
PHD2-haplodeficiency has been implicated with macrophage polarization and increased 
arteriogenesis. In vitro data show a metabolic impairment in PHD2-deficient macrophages, 





effects had an influence on sterile inflammation in vivo, where both phagocytosis and 
migration play a vital role, a myeloid-specific knock out mouse was studied in a model of 
myocardial infarction. The following questions were addressed: 
1. How does myeloid PHD2-deficiency affect heart function after myocardial infarction? 
2. Is the course of inflammation altered in myeloid-specific PHD2-deficient mice after 
myocardial infarction?




2. Material and methods 
2.1 Material 
2.1.1 Antibodies, isotype controls and cell dyes used for flow cytometry 
All antibodies were purchased from Biolegend with the exception of CD120b (BD Horizon) 
and its respective isotype control (BD Horizon). All cell dyes used for flow cytometry were 
purchased from Biolegend. 
Table 1: Antibodies for flow cytometry. 
Antibody Coupled 
fluorophore 







none Rat 10  93 101319 
Anti-mouse/ 
human CD11b 
APC Rat 0.4  M1/70 101211 
Anti-mouse/ 
human CD11b 
PE/Cy7 Rat 0.1  M1/70 101215 
Anti-mouse Ly-6G FITC Rat 0.1 127605 127605 
Anti-mouse F4/80 FITC Rat 2 BM8 123107 
Anti-mouse F4/80  PE Rat 0.4 BM8 123109 
Anti-mouse I-Abb PE Rat 0.4 AF6-120.1 116407 
Anti-mouse CD86 PE Rat 0.4 GL-1 105007 
Anti-mouse CD120b BV421 Hamster 0.4 TR75-89 564088 
Anti-mouse CD206 PE/Cy7 Rat 0.4 C068C2 141719 
Anti-mouse CD120a PE Armenian 
hamster 
0.4 55R-286 113003 
 
Table 2: Isotype controls for flow cytometry. 













0.4  RTK4530 400611 




0.1  RTK4530 400617 




0.1 RTK2758 400505 




2  RTK2758 400505 





0.4 RTK2758 400507 











0.4 RTK2758 400521 
Armenian hamster 
IgG isotype ctrl 
PE CD120a-
PE 
0.4 HTK888 400907 





Table 3: Cell dyes used for flow cytometry. 
Dye Coupled fluorophore Dilution Catalog number 
Annexin V Pacific Blue 1:50 640917 
Zombie fixable Viability 
kit 
FITC 1:1000 423111 
 
2.1.2 Antibodies used for immunofluorescence and Western blot 
Antibodies used for immunofluorescence on cryosections and for Western blotting are listed 
below. 
Table 4: Antibodies used for immunofluorescence. 





1:200 Invitrogen I21411 
Vinculin Rabbit 1:100 Sigma  V9264-200UL 
TR-coupled 
anti mouse 
Goat 1:200 Santa Cruz Sc-2781 
 
Table 5: Antibodies used for Western blots. 
Antibody Raised in Dilution Company Catalog number 
Anti-HIF-1α Mouse 1:1000 Novus 
Biologicals 
NB-100-479 
Anti-PHD2 Mouse 1:1000 Novus 
Biologicals 
NB-100-2219 
Anti-PHD3 Rabbit 1:500 Novus 
Biologicals 
NB-100-303 
Anti-β-Actin Mouse 1:10000 Sigma A5441 
HRP-coupled 
anti-rabbit 









2.1.3 Primer lists 
Genotyping of mice was performed in a PCR using the following primers (table 5) at the 
indicated annealing temperatures. Gene expression of cells was tested using primers for 
qRT-PCR in table 6. For detection of miRNA-511, commercially available primers were used. 
Table 6: Primers for genotyping. 




fw 5´-GTT CGC AAG AAC CTG ATG GAC A-3´ 60 
rev 5´-CTA GAG CCT GTT TTG CAC GTT C-3´ 
PHD2flox  
 
fw 5´-CTC ACT GAC CTA CGC CGT GT-3´ 53 
rev 5´-CGC ATC TTC CAT CTC CAT TT-3´ 






fw 5´-CCA CGT TAA CTC TAG AGC CAC TGA-3´ 58 
rev 5´-ATG GCC GCT GTA TCA CCT GTA T-3´ 
  






Cyp2s1 fw 5´-TGC TCC TGC TGA GAT ACC CT-3´ 58 
rev 5´-GAA GCA AGT GGT CCT CGT GA-3´ 
IL-6 fw 5´-GTG GGC CAC CAG CAG CTC AG-3´   58 
rev 5´-GCT GGT GAC AAC CAC GGC CT-3´   
IL-12b fw 5´-CTT CAT CAG GGA CAT CAT CAA ACC A-3´ 58 
rev 5´-CCT TTG CAT TGG ACT TCG GT-3´ 
iNOS fw 5´-AAG TCC AGC CGC ACC ACC CT-3´ 62 
rev 5´-TCC GTG GCA AAG CGA GCC AG-3´ 
MCP-1 fw 5´-GCT CAG CCA GAT GCA GTT AAC GCC C-3´ 58 
 rev 5´-CCT TCT TGG GGT CAG CAC AGA CCT-3´   
PHD2  fw 5´-TTG CTG ACA TTG AAC CCA AA-3´ 60 
 rev 5´-GGC AAC TGA GAG GCT GTA GG-3´ 
PHD3 fw 5´-GGC CGC TGT ATC ACC TGT AT-3´ 60 
rev 5´-TTC TGC CCT TTC TTC AGC AT-3´ 
Rbm4 fw 5´-CAC TGT TGG AGA GGG CTA CG-3´ 60 
rev 5´-TTC CTG GGG ACT GAA TGC AC-3´ 
S12  fw 5´-GAA GCT GCC AAG GCC TTA GA-3´ 60 
rev 5´-AAC TGC AAC CAA CCA CCT TC-3´ 
TNF-α  fw 5´-GAC CCT CAC ACT CAG ATC ATC TTC-3´ 58 
rev 5´-CCA CTT GGT GGT TTG CTA CGA-3´ 
  
Table 8: Primers for miRNA detection by qRT-PCR. 
Primer Catalog number Company 
Universal Adaptor primer P01011A GeneCopoeia 
Mmu-miR-511-3p MmiRQP3338 GeneCopoeia 
Mmu-miR-511-5p MmiRQP1067 GeneCopoeia 
Mouse snRNA U6 MmiRQP9002 GeneCopoeia 
 
2.1.4 Kits 
The following kits were used for the studies of cytokine levels and gene expression analyses. 
Table 9: Kits used. 
Name Order number Company 
Cytometric bead array 552364 BD Biosciences 
SensiMixTM SYBR® Low-ROX kit QT625-05 Bioline 
First Strand cDNA Synthesis kit K1612 
 
Thermo Fisher Scientific 
All-in-One miRNA First-Strand 




DNase I kit 04716728001 Roche  
Immobilon Western WBKLS0500 Merck Millipore 




Chemiluminescent HRP Substrate  
Prostaglandin E2 ELISA Kit ab136948 abcam 
PCR Master Mix (2x) K0171 Thermo Fisher Scientific 




2.1.5 Cell lines 
All cell lines were purchased from ATCC. 
Table 10: Cell lines used to create conditioned medium. 
Cell line Origin Original publication Specification 
L929 Murine, connective tissue (Sanford et al., 1948) #CCL-1 
MDA-MB231 Human, breast cancer (Cailleau et al., 1974) #HTB-26 
 
2.1.6 Cell culture media 
All cell culture ingredients were purchased from PAN Biotech (Aidenbach, Germany) with the 
exception of β-mercaptoethanol, which was purchased from Carl Roth GmbH (Karlsruhe, 
Germany). 
Table 11: Composition of cell culture media used. 
Medium Ingredients Catalog number 
Neutralization 
medium 
Dulbecco´s modified eagle medium 
(DMEM) 
15% fetal calf serum (FCS) 
100 U/ml penicillin 





Culture medium DMEM 
10% fetal calf serum 
0.2 mM glutamine 
0.2 M HEPES 
0.1 mM sodium pyruvate 
50 U/ml penicillin 








Pluznik´s medium DMEM 
30% L929-conditioned medium 
10% fetal calf serum 
5% horse serum 
0.1 mM sodium pyruvate 
50 U/ml penicillin 










Starvation medium DMEM 
50 U/ml penicillin 









2.1.7 Buffers and staining solutions 
The following buffers and staining solutions were prepared according to the information 
provided below. 
Table 12: Ingredients of buffers and their concentrations. 
Buffer Ingredients Catalog number Company 
Phosphate buffered 
saline (PBS) 
137 mM NaCl 
2.7 mM KCl 
10 mM Na2HPO4 





Carl Roth GmbH 
Carl Roth GmbH 
Carl Roth GmbH 
Carl Roth GmbH 
Mowiol solution 3% glycerine 
1.33% mowiol 






Carl Roth GmbH 
Sigma Aldrich 
Carl Roth GmbH 
Carl Roth GmbH 






Tail lysis buffer for 
genotyping 
25 mM NaOH 
0.2 mM EDTA 
6771.1 
8043.2 
Carl Roth GmbH 
Carl Roth GmbH 
Neutralization buffer 
For genotyping 
40 mM Tris/HCl pH 5.0 9090.1 Carl Roth GmbH 
TBE 0.5x 45 mM Tris  
45 mM Boric acid 





Carl Roth GmbH 
Carl Roth GmbH 
Carl Roth GmbH 
Washing buffer for 
flow cytometry 









Carl Roth GmbH 
Digestion buffer for 
hind limb tissue 
450 U/ml collagenase IV 






Digestion buffer for 
heart tissue 
600 U/ml collagenase IV 















Carl Roth GmbH 
Blocking solution 
immunofluorescence 
10% Normal goat serum 





Carl Roth GmbH 
Cell lysis buffer  400 mM NaCl 
10 mM Tris/HCl, pH 8.0 
1 mM EDTA, pH 8.0 






Carl Roth GmbH 
Carl Roth GmbH 
Carl Roth GmbH 
Carl Roth GmbH 
2x SDS sample 
buffer 
100 mM Tris/HCl pH 6.8 
4% SDS 










Carl Roth GmbH 
Carl Roth GmbH 
Carl Roth GmbH 
Carl Roth GmbH 
Carl Roth GmbH 
 
5x SDS 125 mM Tris 5429.3 Carl Roth GmbH 






1.25 M glycine 
0.5% SDS 




Carl Roth GmbH 
Carl Roth GmbH 
Western blot transfer 
buffer 
25 mM Tris 









Carl Roth GmbH 
Carl Roth GmbH 
Carl Roth GmbH 




100 mM Tris/HCl, pH 8.5 
90 mM coumaric acid 






Carl Roth GmbH 
Sigma 
Carl Roth GmbH 
Sigma 
Ponceau S solution 0.1% Ponceau 




Carl Roth GmbH 
 
2.1.8 Chemicals 
The following chemicals were used for experiments. 
Table 13: List of chemicals used. 
Chemical Order number Company 
Agarose Broad Range T846.3 Carl Roth GmbH 
Gene Ruler DNA ladder 1kb SM0311 Thermo Scientific 
Roti Safe Gel Stain 3865.1 Carl Roth GmbH 
Chloroform 3313.1 Carl Roth GmbH 
Isopropanol 6752.4 Carl Roth GmbH 
Ethanol 9065.4 Carl Roth GmbH 
Xylol 9713.1 Carl Roth GmbH 
TRIzol 15596018 Ambion 
Dako Diluent S0809 Dako 
Tissue-Tek O.C.T. 4583 Sakura 
Acetone 9372.1 Carl Roth GmbH 
Methanol 4627.5 Carl Roth GmbH 
Hoechst D1306 Thermo Scientific 
Roti Histokitt T160.1 Carl Roth GmbH 
RNase-free water R0581 Thermo Scientific 
Paraformaldehyde  0335.1 Carl Roth GmbH 
Percoll 17-0891-02 GE Healthcare 
Phenol/Chloroform/Isoamylalcohol A156.3 Carl Roth GmbH 
Evan´s Blue E2129-10G Carl Roth GmbH 
2,3,5-Triphenyltetrazolium chloride T8877-56 Sigma 
10x Hank´s balanced salt solution P04-49100 PAN Biotech 
 
2.1.9 Equipment 
The following equipment was used for experiments. 
Table 14: Surgery equipment. 
Consumable Order number Company 
0.9% NaCl solution 2000277 Braun Melsungen AG 
Ketamine 10% 04-03-9264/23 Medistar 




Xylariem (Xylazine) 1246626/11 Ecuphar 
Forene (Isoflurane) 100% 
(v/v) 
B506 Abbvie 
500 mg/ml Novaminsulfon 
(Metamizol) 
PZN-03530402 Ratiopharm 
Heparin 25000 I.U/5 ml PZN-03862340 Rotexmedica 
Prolene thread 9-0 8889-H Ethicon 
Silk thread 6/0 4208 Resorba 
26 gauge Sterican needle 4665427 Braun Melsungen AG 
25 gauge Sterican needle 4657675 Braun Melsungen AG 
Omnifix 40 solo syringe 9161309V Braun Melsungen AG 
Thilo-Tears gel (eye crème) 530/28292-2 Alcon Pharma GmbH 
K+ EDTA tubes 41.1395.005 Sarstedt 
Lithium heparin tubes 41.1502.005 Sarstedt 
 
Table 15: Consumables. 
Consumable Company 
Superfrost coverslide Thermo Scientific 
Menzel coverslide Thermo Scientific 
Eppendorf cups Sarstedt 
Cell culture dish 100, Standard Sarstedt 
Petri dish 100, with cams Sarstedt 
Petri dish 35, with cams Sarstedt 
Round bottom polystyrene tubes (flow cytometry) Falcon 
70 µm Cell Strainer Falcon 
40 µm Cell Strainer Falcon 
Pipette tips: 10 µl, 200 µl, 1000 µl Sarstedt 
 
2.1.10 Devices 
The following devices were used for experiments. 
Table 16: Lab and surgery devices. 
Instrument Application Company 
RotaRod Advanced V4.3.0 Motor function TSE Systems GmbH 
Vevo 2100 Imaging system  Ultrasound Visualsonics 
PeriScan PIM3 Laser Dopper Perfusion hind limb ischemia Perimed 
Stemi 2000-c microscope Surgery Zeiss 
Hot plate ST983 Surgery Vogel 
Mantis Elite microscope Surgery Vision Engineering 
Mini Vent Type 845 Surgery- Ventilation Hugo Sachs Elektronik 
Vapor 19.3 Halothane Surgery- gas mix Drägerwerk AG 
Elektrotom B50 Surgery Martin 
Bipolar forceps 20195-020 Erbe 
KL1500 LCD Surgery-light source Schott 
Surgical instruments  F.S.T. 
FACS Canto II Flow cytometry Beckton Dickinson 
FACS Aria III Cell sorting Beckton Dickinson 
Centrifuge 5810R for falcons Cell culture Eppendorf 
Hera Safe clean bench Cell culture Thermo Electron 
Cooperation 




Sci-tive Hypoxia workstation Single cell migration Baker Ruskinn 
Nikon ECLIPSE TS100 Single cell migration Nikon 
Digital Sight DS-L3 screen Single cell migration Nikon 
AE30 Inverted Microscope Cell culture Motic 
5415R Centrifuge for tubes  Eppendorf 
Primus 96 PCR cycler PCR PeqLab 
Mx300P light cycler qRT-PCR Stratagene 
Fume hood  Köttermann 
NanoDrop 2000c RNA concentration Thermo Scientific 
Microm HM560 cryotome Cryosections Thermo Scientific 
Microm HM 355S microtome Paraffin sections Thermo Scientific 
Zeiss microscope, 40x  Imaging Zeiss 
Nikon microscope SMZ 1500 Imaging Nikon 
Digital Sight camera Imaging Nikon 
Gene Flash Gel 
Documentation 
Genotyping PCR Syngene Bio Imaging 
Fine scale AC 2115  Sartorius 
Universal scale   Sartorius 
Neubauer counting chamber Cell culture Marienfeld 
 
Table 17: Software.  
Software Application Reference 
PIMSoft Laser Doppler Imaging Perimed 
Flowing software 2.5.1 Flow cytometry Perttu Terho, Turku Centre for 
Biotechnology, Finland 
RotaRod V4.3.0 (4965) Motor function assay  TSE Systems GmbH 
FCAP Array software Cytokine bead assay BD Biosciences 
DeSeq2 software RNA sequencing Bioconductor 
Pro Size software Fragment analysis Advanced Analytical Technologies 
FACS DIVA software Flow cytometry Beckton Dickinson 
Graph Pad prism Data analysis GraphPad Software 
Corel Draw Data display Corel Cooperation 
MxPro qRT-PCR analysis Agilent Technologies 
Axiovision Acquiring of images Zeiss 
ImageJ Image analysis NIH 
NanoDrop software RNA concentration Thermo Scientific 
 
2.2 Methods 
2.2.1 Mouse models 
2.2.1.1 Myeloid-specific PHD3 knock out mice 
PHD3flox/flox mice were kindly provided by Prof. Guo-Hua Fong (Center for Vascular Biology, 
University of Connecticut Health Center, Farmington, CT, USA). In these mice, PHD3 exon 2 
is flanked by loxP sites. Generation and detailed characterization of the mice are described 
elsewhere (Takeda et al., 2006). All animals in this study were backcrossed to C57BL/6 mice 
at least five times. PHD3flox/flox mice were crossed with LysMcre mice (Clausen et al., 1999), 
which were purchased from the Jackson Lab to generate PHD3flox/flox × LysMcre+/− mice 
within two generations. PHD3flox/flox × LysMcre+/− mice were then crossed with PHD3flox/flox 




mice to obtain PHD3−/− mice (PHD3flox/flox × LysMcre+/−) and littermate control wild type mice 
(PHD3flox/flox × LysMcre-/−). The initial breeding of PHD3flox/flox×LysMcre+/− mice was performed 
by Dr. Katja Farhat, a former Postdoc of the Institute of Cardiovascular Physiology. 
2.2.1.2 Myeloid-specific PHD2 knock out mice 
All animals in this study were backcrossed to C57BL/6 mice at least five times. PHD2flox/flox 
mice were kindly provided by Prof. Ben Wielockx (Dresden University, Germany). In these 
mice, PHD2 exons 2 and 3 are flanked by loxP sites. Generation and detailed 
characterization of the mice are described elsewhere (Singh et al., 2013). PHD2flox/flox × 
LysMcre+/- mice were crossed with PHDflox/flox mice to obtain PHD2-/- (PHD2flox/flox × LysMcre+/-
) mice and littermate control wild type mice (PHD2flox/flox × LysMcre-/-). The initial breeding of 
PHD2flox/flox × LysMcre+/− mice was performed by Dr. Katja Farhat, a former Postdoc of the 
Institute of Cardiovascular Physiology. 
2.2.1.3 Genotyping 
Tail biopsies from 3-4 week old mice were incubated in 75 µl tail lysis buffer for 60 min at 
95 °C. The alkaline lysis of the tissue was stopped by incubating the samples on ice for 10 
min and adding the same amount of genotyping neutralization buffer.  
To test for the presence of a cre recombinase or floxed PHD2 or PHD3 allele, a polymerase 
chain reaction (PCR) was performed. 5 µl of DNA-containing lysate was mixed with 12.5 µl 
PCR Master Mix (2x) and 0.1 pmol/µl reverse and forward primers for PHD2flox, PHD3flox or 
cre recombinase and H2O in a final volume of 25 µl. The PCR was run according to the 
following temperature settings: 
Table 18: Temperature profile for genotyping PCRs. 
Step Temperature [°C] 
Cre         PHD2flox      PHD3flox 
Time [sec] 
Cre          PHD2flox       PHD3flox 























The sequence of denaturation annealing and elongation steps was repeated for 30 (Cre, 
PHD2flox) or 40 (PHD3flox) cycles. The PCR product was mixed with 5 µl Orange G and 
loaded on a 1.5% agarose-gel in 0.5x TBE buffer containing Roti Safe together with a 1 kb 
DNA ladder to estimate product size. The PCR product for cre recombinase was around 
350 bp long, the one for PHD2flox 400 bp (wild type no band), and the one for PHD3flox 840 bp 
(wild type band at 400 bp). Bands were visualized in a UV gel documentation station. 




2.2.2 Surgery techniques and associated analyses 
2.2.2.1 Hind limb ischemia 
Peripheral artery disease (PAD) occurs most commonly after formation of an atherosclerotic 
plaque in an artery supplying the leg, which can ultimately lead to its complete occlusion. An 
established model to study PAD in mice is the permanent ligation of the femoral artery 
(Limbourg et al., 2009; Niiyama et al., 2009). The femoral artery of the mouse is the main 
supplier of blood and nutrients to the hind limb muscles. It originates from the common iliac 
artery and enters the thigh as common femoral artery behind the inguinal ligament. It then 
gives rise to several collaterals, among those the proximal caudal femoral artery which 
supplies the adductor muscles superficially as well as the medial hamstring muscles (Kochi 
et al., 2013). This artery was referred to as arteria profunda femoris by Limbourg and 
colleagues (Limbourg et al., 2009).  
Ligation of only the femoral artery proved to be a valid model to study both arteriogenesis 
and angiogenesis in murine models of hind limb ischemia (Limbourg et al., 2009). However, 
the induction of ischemia is rather mild and, depending on the mouse strain, not always 
sufficient. It has been demonstrated before that especially mice with a C57Bl/6 background 
are more resistant towards induction of ischemia which is most likely caused by strain-
dependent differences in collateral vasculature (Greenberg et al., 2008). This is why in this 
study I ligated both femoral artery and proximal caudal femoral artery proximally to the 
bifurcation. After a second ligation at the knee joint, the femoral artery was completely 
removed without damaging the associated femoral vein and nerve. This caused a sufficient 
drop in perfusion, which was only partially recovered until day 28 after surgery. 
All animal experiments were performed according to the German animal protection law and 
approved by the Niedersächsisches Landesamt für Verbraucherschutz und 
Lebensmittelsicherheit in Oldenburg (animal experimentation number 33.9-42502-04-
11/0413). 8-12 week old male wild type and PHD3-/- mice underwent hind limb ischemia. To 
induce anesthesia, mice were injected with a mixture of ketamine (75 mg/kg body weight) 
and xylazine (15 mg/kg body weight) in 0.9% NaCl-solution. Mice were fixed underneath a 
microscope on a hot plate (37 °C) using adhesive tape. The right leg was disinfected using 
70% ethanol and a small incision was made on the level of the knee joint. The femoral artery 
was separated from the accompanying vein and nerve and ligated using a silk thread (6/0). 
The artery was then cauterized at the distal side of the ligation. A second incision was made 
just below the groin. Again, the femoral artery was separated from the accompanying vein 
and nerve, and a second ligation was done proximal of the bifurcation of femoral artery and 
the proximal caudal femoral artery. Both femoral artery and proximal caudal femoral artery 




were cauterized at the distal side of the ligation. The femoral artery was then removed and 
the two incisions were closed using prolene thread.  
Mice received metamizol to relieve them from pain caused by the surgery and the following 
ischemia. Metamizol was given 2 days before surgery until 5 days after surgery via the 
drinking water in a final concentration of 1.33 mg/ml. 
Mice that showed severe signs of indisposition (lethargy, weight loss over 20%) and mice 
that developed a severe necrosis spreading to the whole limb were excluded from the study.  
2.2.2.2 Laser Doppler imaging 
Laser Doppler imaging is a widely used and non-invasive method to quantify blood flow. A 
low power laser beam (658 nm) that penetrates the skin around 200-300 µm deep is used to 
scan the tissue (Jakobsson and Nilsson, 1993). Moving objects like erythrocytes scatter the 
light waves and change their wavelength (Dopplershift) while resting objects scatter the light 
waves without changes in wavelength. The Dopplershift can be detected by a photo-detector 
and transformed into color-coded images which represent the perfusion of the upper skin 
levels of the tissue. Only the hairless hind paws were analyzed, and not the whole limb, 
because the fur can influence the recording. Measuring the paws has been shown to 
correlate well with the perfusion mediated by the femoral artery (Limbourg et al., 2009). 
The perfusion in hind paws was analyzed via laser Doppler imaging while mice were 
anesthetized (ketamine 75 mg/kg body weight, xylazin 15mg/kg body weight in 0.9% NaCl-
solution). Mice were placed on a hot plate at 37 °C and their paws were fixed in the scanning 
region (3.2 cm width and 2.1 cm height) with adhesive tape. Pictures were taken before and 
directly after surgery, as well as on the day of tissue isolation. Mice were additionally 
analyzed on day 7, 14 and 21 after surgery if they were studied for 28 days. 
Color-coded images were analyzed using the PIMsoft software. Regions of interest (ROI) 
were drawn around the hind paws with a maximum of 5% difference in area between right 
and left paw. The mean perfusion values of the ligated leg were then normalized to the 
values of the unligated leg. 
2.2.2.3 Assessing motor function 
Motor function was assessed before and after hind limb ischemia to evaluate whether one 
group recovered faster after surgery. Two different methods were used to assess motor 
function: 
2.2.2.3.1 Grading system 
In order to evaluate to which degree mice made use of the operated leg, the mouse was 
placed in a cage and observed while freely moving around. The bottom of the cage was 




covered with paper to avoid slipping. The ability to move the ligated leg was graded 
according to the following parameters (adapted from (Rishi et al., 2015)): 
Table 19: Grading scores for impairment of leg movement after hind limb ischemia. 
Grade Description 
1 Inability to move the whole limb 
2 Inability to move the foot 
3 Mouse makes a claw, cannot spread toes 
4 Ability to move the foot and toes, but tendency to adopt a relieving posture 
5 No impairment at all 
 
Mice were checked before surgery and once every postsurgical day until day 7, when none 
of the tested mice showed any impairment anymore. 
2.2.2.3.2 RotaRod running test 
A RotaRod system is a device with a rotating rod, on which a rodent can be placed in order 
to measure running capacity. In the RotaRod system used here (RotaRod Advanced, TSE) 
the rod was accelerated in order to test which maximum speed a mouse can still run. Mice 
that could not keep up anymore fell onto a grid, which was detected by a light sensor. The 
maximum speed at which the mice were still able to keep themselves on the rod was 
recorded.  
Mice had to get used to the RotaRod device before the experiment. In order to get them 
acquainted with the system and reduce the influence of learning behavior on the outcome of 
the experiment, mice were trained prior to the surgery. The following table gives an overview 
over the training program and the recording program: 




From        To 
Remarks 
Training day 1 30 10 10  
Training day 2 15 10 10  
 10 None  Mouse was placed back into the cage to 
rest 
 4 10 40 4 runs 
Recording day 5 10 10 Warm up 
 4 10 40 4 recorded runs  
 
Mice were trained for two days before surgery. 4 recorded runs were performed one day 
before surgery, as well as on day 7, 14, 21 and 27. Before each recorded run, mice were 
allowed to adjust to the rod for 5 min at a constant speed of 10 rpm. For data analysis, the 
arithmetic mean of the 4 runs was calculated. 




2.2.2.4 LAD ligation 
A widely used model to study the effects of myocardial infarction in rodent models is the 
permanent occlusion of the left anterior descending artery (LAD). By occlusion of the LAD, a 
large part of the left ventricle at the tip of the heart is not properly perfused anymore, which 
ultimately leads to an inflammatory reaction, scar formation and impaired heart function.  
LAD ligation surgeries were performed by Dr. Liza Swain, a Postdoc of the Institute of 
Cardiovascular Physiology. Animal experiments were performed according to the German 
animal protection law and approved by the Niedersächsisches Landesamt für 
Verbraucherschutz und Lebensmittelsicherheit in Oldenburg (animal experimentation number 
33.9-42502-04-12/0833). 10-12 week old female wild type and PHD2-/- mice underwent LAD-
surgery. Mice were injected with buprenorphine (0.1 mg/kg body weight) 30 min before 
surgery for analgesia. Narcosis was induced with a gas mixture containing 2.5-3.5% 
isoflurane in O2 and maintained with 0.75-2% isoflurane in O2. Mice were intubated and 
mechanically ventilated with a respiratory rate of 150 breaths/min and a breathing volume of 
150 µl. After a thoracotomy, the left anterior descending artery was occluded using 9-0 
prolene thread just below the left atrial auricle. Successful ligation led to a decoloring of the 
heart muscle distal to the ligation. Surgery wounds were then sutured and mice were 
extubated after they started to breathe spontaneously. Sham surgeries were performed with 
the same procedure as LAD surgeries just without ligation of the artery. 
To relieve mice from pain, they were subcutaneously injected with buprenorphine (0.1 mg/kg 
body weight) twice a day for 3 days after surgery. In addition, mice received metamizol 
(1.33 mg/ml) 2 days before until 7 days after surgery with their drinking water. Mice that 
showed over 20% loss of body weight within 24 hrs, a low body temperature, signs of pain or 
lethargy and inability to move were excluded from the experiment. 
Hearts were harvested 3 or 7 days after surgery for flow cytometric analysis (see 2.2.3.2). 
2.2.2.5 Echocardiography 
Echocardiography is a non-invasive method to examine the heart via ultrasound. The 
thickness of the heart walls as well as heart function parameters can be determined via this 
method.  
Echocardiography was performed by Dr. Aline Jatho, a Postdoc of the Institute of 
Cardiovascular Physiology. Mice that underwent LAD-surgery underwent echocardiography 
before and 6 days after surgery. The examination was performed while the mouse was 
anesthetized (1% isoflurane in an O2-mixture). 10 cardiac cycles were recorded in B-mode to 
visualize the long axis and the short axis of the heart. The echocardiography device was then 
switched to M-mode to measure the heartbeat with a high temporal resolution. Another 10 




cardiac cycles were recorded in M-mode visualizing the short axis. Different parameters like 
thickness of the posterior and anterior walls as well as area of the lumen during diastole 
(Area(d)) and systole (Area(s)) and length of the long axis (L(d) and L(s)) of the heart were 
determined. The ejection fraction (EF [%]) describes how much blood is distributed by the 
heart with each heartbeat. It was calculated by the following formula: 
   
             
      
     
Vol(d) and Vol(s) are the abbreviations for the volume of the left ventricle during diastole and 
systole respectively. They were calculated using the following formulas: 
        
 
 
                 
        
 
 
                 
The fractional area shortening (FAS [%]) describes to which degree the area of the left 
ventricle changes during each heartbeat. It was calculated by the following formula: 
    
               
       
     
2.2.2.6 Blood collection 
Blood was taken from anesthetized mice (ketamine 75 mg/kg body weight, xylazine 15mg/kg 
body weight in 0.9% NaCl-solution). The abdominal cavity was opened with a V-cut. 
Intestines were shifted to the left side in order to expose the vena cava (Hoff, 2000). A 26 
gauge needle was used to slowly draw blood from the vena cava. Blood was collected in K+ 
EDTA tubes and spun down for 5 min at 5000 rpm to separate plasma from erythrocytes and 
buffy coat. Plasma was carefully separated from the other phases and stored in 50 µl 
aliquots at -80 °C until it was used for measuring plasma cytokines (see 2.2.3.3). 
2.2.3 Flow cytometric analyses and sorting 
Flow cytometry enables to characterize and distinguish cells via various optical parameters. 
For that, a stream of cells has to pass an argon laser. The cells are focused by the 
surrounding fluids so that only one cell at a time passes the laser. When meeting the cell, the 
laser beam is scattered into different directions which can be detected in a forward (FSC) 
and sideward scatter (SSC). The FSC is a measure of cell size while the SSC characterizes 
the intracellular complexity. Apart from that, the light from the laser excites fluorophores, by 
which the cells can be labelled. The resulting emission of characteristic spectra can be 
collected via various filters which makes it possible to label cells with different dyes 
simultaneously.  




2.2.3.1 Flow cytometry of hind limb muscles 
In order to evaluate ischemia-induced inflammation after hind limb ischemia surgery, 
gastrocnemicus muscles from the ligated and unligated legs were isolated. To this end, mice 
anesthetized with ketamine (75 mg/kg body weight) and xylazine (15 mg/kg body weight) 
were killed by cervical dislocation. The skin covering the lower limbs and the abdomen was 
disinfected using 70% ethanol and incisions were made in the abdominal zone without 
harming the peritoneum. Starting from those incisions, the skin was removed from the upper 
leg all the way down to the paw. The gastrocnemicus muscle is partially covered by the 
adductor, which had to be removed. Gastrocnemicus muscles were excised by detaching 
them at the hamstring and at the knee joint.  
Muscles were then cut into small pieces, suspended in 5 ml of digestion buffer and incubated 
for 45 min at 37 °C and 180 rpm in a shaker. During this time, the tissue was further 
disrupted by pipetting the solution up and down every 15 min using first a 10 ml pipette and 
then a 5 ml pipette. Digestion was stopped by adding 15 ml ice cold neutralization medium. 
The samples were filtered through a 70 µm mesh and subsequently through a 40 µm mesh 
to get rid of tissue residues. The samples were centrifuged at 400 x g for 10 min. After 
removing the supernatant, cells were resuspended in 2 ml of washing buffer and counted 
using a Neubauer counting chamber.  
An equal number of cells (between 300.000 and 500.000) were then distributed into FACS-
tubes in 1 ml of washing buffer and centrifuged at 450 x g for 5 min. After removing the 
supernatant, unstained CD16/CD32 antibody was added for 15 min at 4 °C to block 
unspecific binding sites. After that antibodies against certain surface markers were added at 
the indicated final concentrations (see table 1 and 2) to identify different cell populations: 
 






1 Ly-6G-FITC Leukocytes CD11b+ 
I-Abb (MHCII)-PE Neutrophils Ly-6G+ MHCIIlow CD11b+ 
CD11b-PE/Cy7   
2 F4/80-FITC Leukocytes CD11b+ 
CD86-PE Macrophages F4/80+ CD11b+ 
CD206-APC M1-polarization Geometric mean fluorescence 
intensity of CD86 within the F4/80+ 
CD11b+ population 
CD11b-PE/Cy7 M2-polarization Geometric mean fluorescence 
intensity of CD206 within the 
F4/80+ CD11b+ population 




3 F4/80-FITC Leukocytes CD11b+ 
CD11b-APC Macrophages F4/80+ CD11b+ 
CD120a (TNF-R1)-
PE 
TNF-R1 Geometric mean fluorescence 




TNF-R2 Geometric mean fluorescence 
intensity within the F4/80+ CD11b+ 
population 
4 F4/80-PE Macrophages F4/80+ CD11b+ 
CD11b-APC Living cells Annexin V- Zombie Greenlow F4/80+ 
CD11b+ 
Annexin V Early apoptotic cells Annexin V+ Zombie Greenlow 
F4/80+ CD11b+ 
Zombie Green Late apoptotic cells Annexin V+ Zombie Greenhigh 
F4/80+ CD11b+ 
Dead cells Annexin V- Zombie Greenhigh 
F4/80+ CD11b+ 
 
Samples were incubated with antibody mixtures for 30 min at 4 °C. Afterwards, cells were 
washed once in washing buffer or in Annexin V-staining buffer (staining protocol 4).  
Cells were measured using the FACS Canto II flow cytometer. A compensation was done for 
all staining protocols. The compensation setup required single-stained representative 
samples as well as one unstained control sample. The voltage of each laser was adjusted in 
a way that positive and negative populations were clearly visible. Positive cell populations 
were gated and the compensation was calculated by the FACS Diva software. 
In order to correctly distinguish positive and negative cell populations in a sample, 
fluorescence minus one (FMO) controls were created, using all antibodies at the given 
concentrations except one which was replaced by the respective IgG control.  
Acquired data were analyzed using the freely available Flowing software 2.5.1 developed by 
Perttu Terho. 
2.2.3.2 Flow cytometry of heart tissue 
In order to quantify immune cells after the induction of myocardial infarction, hearts were 
isolated from mice that underwent LAD or a sham operation. Mice were killed by cervical 
dislocation under anesthesia and hearts were extracted. Hearts were flushed once with 1 ml 
0.9% NaCl solution by cannulating the aorta under the microscope.  
Hearts were dissected into very small pieces. Minced hearts were suspended in digestion 
buffer and incubated at 37°C for 45 min at 180 rpm in a shaker.  




Further processing of the tissue was performed as described above for hind limb muscles, 
with the addition of an erythrocyte lysis step, which was implemented after the first 
centrifugation. After this centrifugation step, the supernatant was removed and cells were 
resuspended in 10 ml 0.2% NaCl solution. After 15 sec, an equal amount of 1.6% NaCl 
solution was added and cells were centrifuged at 400 x g for 10 min at 4 °C. After that the 
supernatant was removed and cells were resuspended in 2 ml washing buffer, counted and 
processed as described above. Staining protocols 1 and 2 were used to identify populations 
of leukocytes, neutrophils, macrophages and macrophage polarization. 
2.2.3.3 Flow cytometric measurement of cytokines from plasma 
In order to evaluate systemic signs of inflammation after hind limb ischemia surgery, the 
abundance of pro- and anti-inflammatory cytokines was tested in blood plasma. Plasma 
taken from mice 1, 3, 5 and 7 days after surgery was evaluated, as well as plasma from 
resting mice, which served as negative control.  
Cytokines were detected using a cytometric bead assay kit (BD Biosciences). In short, 
plasma was incubated with a mix of beads that specifically bound to the cytokines IL-6, IL-10, 
MCP-1, IFN-ɣ, TNF or IL-12p70, respectively. In order to detect the cytokine-bound beads, a 
PE-labelled detection reagent was added. After 2 hrs of incubation, beads were washed and 
measured using the FACS Canto II flow cytometer. Different cytokine beads could be 
differentiated by their distinctively different intensity in the APC channel. Abundance of 
cytokines was measured via the mean fluorescence intensity in the PE channel. Cytokine 
concentrations were determined with the help of a calibration curve using the inflammation 
standard provided by the kit. Data were analyzed using the FCAP ArrayTM software. 
2.2.3.4 RNA sequencing 
Macrophages were isolated from the gastrocnemicus muscle of mice 5 days after hind limb 
ischemia surgery as described above (2.2.3.1). Tissue lysates were washed one time in 
washing buffer and then stained with antibodies against F4/80-PE and CD11b-APC. 
Doublets were discriminated using SSC-A vs SSC-W gating. The cell population positive for 
both markers was selected and sorted via a FACS Aria III flow cytometer into 1 ml of TRIzol.  
RNA was isolated according to the manufacturer´s instructions. In short, 200 µl of chloroform 
was added to the sample to generate a phase separation. After centrifugation at 12000 x g 
for 15 min at 4 °C, the upper aqueous phase was transferred to a new tube and RNA was 
precipitated by adding 500 µl isopropanol and incubating the sample at -20 °C overnight. 
After centrifugation at 12000 x g for 30 min at 4 °C, the supernatant was removed and the 
RNA pellet was washed by adding 500 µl of 75% ethanol and centrifugating the sample at 
12000 x g for 10 min at 4 °C. The supernatant was removed and this step was repeated a 




second time. The pellet was dried at 37 °C and subsequently dissolved in 10 µl of RNase-
free water and stored at -80 °C until it was further processed. 
The quality of the isolated RNA was assessed by measuring the RIN (RNA Integrity Number) 
using a Fragment Analyzer via PROSize 2.0 software. RNA was prepared for sequencing 
using the TruSeq total RNA Sample Preparation Kit (Illumina). In short, a RNA library was 
prepared according to the following steps: rRNA was depleted, RNA was fragmented and 
cDNA was synthesized using random primers. The 3´-end was adenylated and adaptors 
were ligated to the cDNA. The modified cDNA was further amplified in a PCR reaction using 
primers complementary to the adaptor sequence to enrich cDNAs that were successfully 
linked to adaptors. This RNA library was then sequenced using the Illumina technique. 
The results of the total RNA sequencing were analyzed using DeSeq2 software. Only genes 
that showed a significant log2-fold change of more than 1 or less than -1 between the PHD3
-/- 
and wild type macrophages were included in the candidate list. Statistical significance was 
determined using the Benjamini-Hochberg correction. Adjusted p-values less than 0.05 were 
considered statistically significant. 
2.2.4 Tissue sections and staining techniques 
2.2.4.1 Embedding hind limb muscles for cryosections 
In order to evaluate processes like angiogenesis and fibrosis within the hind limb tissue, 
muscle tissue was taken 3 and 28 days after surgery to study both acute and long term 
effects of ischemia on muscle physiology. 
The gastrocnemicus muscle was extracted from the unligated and ligated hind limb as 
described above. The muscle was then placed on a piece of cork with a drop of frozen 
Tissue-Tek. It was fixed in an upright position (distal end with the hamstring up) using 
needles without piercing the muscle. The muscle was then fully covered with Tissue-Tek and 
snap frozen in liquid nitrogen.  
Tissues were sectioned using the Microm HM560 cryotome. Around 2 mm of the tissue was 
discarded before the first sections were collected on superfrost coverslides. 3 to 4 sections 
with a thickness of 10 µm were collected per coverslide. In total, 24 coverslides were taken 
per muscle. To ensure that also deeper areas of the muscle were represented by the 
sections, around 2 mm of tissue was removed without collecting it after 8 coverslides and 16 
coverslides, respectively.  
2.2.4.2 Immunofluorescence staining of hind limb sections 
Hind limb sections were stained for endothelial cells in order to quantify capillaries and to see 
whether there was a differential angiogenic response between wild type and PHD3-/- mice.  




Cryosections were dried for 60 min at room temperature. After that, they were fixed for 
20 min in a 1:1 mix of acetone and methanol at -20 °C. Tissues were encircled using a fat 
pen and washed twice in PBS. Afterwards, they were blocked for 30 min at room 
temperature in blocking solution. After removing the blocking solution with a quick rinse in 
PBS, sections were stained for 60 min at room temperature with Alexa488-coupled isolectin 
GS-IB4 and an antibody against vinculin in Dako Diluent (dilutions see table 4). Slides were 
then washed 5 times in PBS and incubated with TR-coupled goat anti mouse antibody in 
Dako Diluent for 60 min at room temperature. Slides were washed 6 times in PBS and 
stained using Hoechst (1:500) in PBS for 10 min at room temperature. After that, sections 
were again washed 3 times in PBS and embedded in Mowiol solution.  
Stained sections were imaged using the 40x channel of the Zeiss Observer D1 microscope. 
15-20 images were taken of different areas of the muscle using the same intensity for each 
channel. The amount and average size of capillaries was then measured and normalized to 
the amount of muscle cells in the field of view using ImageJ. 
2.2.4.3 Picro-sirius red staining of hind limb sections 
In order to quantify the extent of fibrosis in hind limbs 28 days after surgery, cryosections 
were stained with picro-sirius red, which stains collagen and elastin fibers red while healthy 
muscle tissue appears in orange.  
Slides were dried for 60 min at room temperature and then incubated two times for 7 min in 
xylol. Slides were then incubated for 5 min each in isopropanol, 99% ethanol, 75% ethanol, 
60% ethanol and distilled water. After that, slides were incubated for 60 min in picro-sirius 
red staining solution. The slides were washed in 1% acetic acid in distilled water two times 
for 3 min to get rid of unspecific staining. Afterwards slides were incubated 3 times for 3 min 
in ethanol and once in xylol for 7 min. Sections were embedded in Roti Histo-kitt. 
Stained sections were imaged in bright-field using the 20x channel of the Zeiss Observer D1 
microscope. The whole section was imaged and analyzed towards its content of picro-sirius-
positive area using ImageJ. Holes in the tissue and borders were excluded from the analysis. 
2.2.4.4 Evan´s Blue staining of infarcted hearts 
The staining of a freshly isolated heart with the dyes Evan´s Blue and TTC (2,3,5-
triphenyltetrazolium chloride) can identify the necrotic area in the infarcted heart as well as 
the area of the heart, which is at risk of dying. The method of Evan´s Blue staining was 
performed by Dr. Anke Zieseniß, a Postdoc of the Institute of Cardiovascular Physiology, and 
has been described before (Vogler et al., 2015). 
Mice underwent LAD surgery. After 6 hrs, mice were injected with heparin (250 IU) and killed 
by cervical dislocation under isoflurane anesthesia. Hearts were isolated, the aorta was 




cannulated and injected with 1% Evan´s Blue. The staining solution was distributed 
throughout the heart via the coronary arteries and stained the well perfused areas of the 
myocardium in blue. Areas that were not stained blue were defined as area at risk (AAR). 
The left ventricle was isolated and sliced into three sections which were incubated in 2% TTC 
for 20 min at 37 °C. Areas that were still viable were stained in red by TTC, while the areas of 
necrosis (AON) stayed pale. To quantify infarct size, images of the heart sections were made 
using the Nikon microscope SMZ 1500. AAR and AON were defined as the average area of 
the slice that was not stained in blue or appeared pale, respectively. The percentage was 
related to the individual weight of the slice. The total infarct size was calculated as AON/total 
AAR. 
2.2.5 Cell cultivation and associated techniques 
2.2.5.1 Cultivation and differentiation of BMDMs 
The bone marrow contains a vast amount of hematopoietic precursor cells, which can be 
differentiated into myeloid cells depending on external stimuli. In order to generate large 
amounts of macrophages, hematopoietic progenitors can be isolated and differentiated in cell 
culture into macrophages. Differentiation of macrophages in Pluznik´s medium is a well-
established technique (Ichikawa et al., 1966; Weischenfeldt and Porse, 2008). Secreted 
factors in L929-conditioned medium such as macrophage colony-stimulating factor (M-CSF) 
provide the stimulus for this differentiation. 
8 to 12 week old mice were killed by cervical dislocation under isoflurane anesthesia and 
femurs were extracted. After cleaning the bones from residue muscle tissue, bones were 
disinfected by incubating them in 70% ethanol and subsequently washing them in PBS. The 
epiphysis on both sides of the bone was cut off with a scissor and the bone was flushed with 
a syringe (26 gauge needle) using 10 ml culture medium. Flushed medium was collected in a 
50 ml tube and was allowed to settle for 10 min in order for pieces of bone to deposit. The 
supernatant was then seeded in a 10 cm surface-treated cell culture dish in order to separate 
non-adherent monocytes from adherent cells like fibroblasts. After 24 hrs, non-adherent cells 
were collected and spun down at 400 x g for 10 min at 4 °C. The pelleted cells were 
resuspended in 50 ml of Pluznik´s medium and spread into 5 bacteria plates. Cells were 
cultivated in Pluznik´s medium for 7 days. During this time, the medium was changed once 
on day 3 of differentiation.  
Cultivating the cells for 7 days in Pluznik´s medium creates a cell population which is 80 to 
90% positive for the macrophage marker F4/80 which can be analyzed by flow cytometry 
(see 2.2.5.4).  




On day 7 in Pluznik´s medium, cells were detached using 3.5 ml accutase per 10 cm plate 
and collected in culture medium. After a centrifugation step at 400 x g for 10 min at 4 °C, 
cells were resuspended in 10 ml culture medium and counted. Cells were then seeded for 
RNA isolation, flow cytometry or single cell migration at the cell densities mentioned in the 
respective chapters. 
An important component of Pluznik´s medium is L929-conditioned medium which was 
created by culturing 4-5x106 L929 cells for 7 days in 50 ml Dulbecco´s modified eagle 
medium (DMEM) with 10% FCS and 1% P/S. The medium was then pooled and spun down 
at 4000 rpm for 20 min at 4 °C and the supernatant was stored in aliquots at -20 °C.  
2.2.5.2 Isolation and enrichment of neutrophils 
The murine bone marrow presents a suitable place to extract high amounts of functionally 
differentiated neutrophils (Boxio et al., 2004). In order to extract them, 8-12 weeks old mice 
were killed via cervical dislocation under isoflurane anesthesia. Femur and tibia of both hind 
limbs were collected.  
Bones were cleaned from residue muscle tissue, disinfected in 70% ethanol and shortly 
washed in PBS. Bones were then flushed with DMEM and filtered using a 70 µm mesh to get 
rid of bone residues. Cell suspensions were spun down at 400 x g for 10 min at 4 °C and the 
pellet was resuspended in 10 ml 0.2% NaCl to lyse erythrocytes. After 15 sec, 10 ml 1.6% 
NaCl was added to stop the lysis and cells were again spun down as described above.  
A 100% Percoll solution was prepared by mixing 9 parts of Percoll solution with 1 part of 
10x Hank´s balanced salt solution (HBSS). This stock solution was then further diluted to the 
desired percentages in 1x HBSS. Cells were resuspended in 3 ml 50% Percoll in HBSS and 
carefully layered onto a gradient made of 3 ml 80% Percoll and 4 ml 65% Percoll in HBSS. 
Percoll gradients were then centrifugated at 1200 x g for 30 min at 4 °C without brake. 
Neutrophils were enriched in the interface between 50% Percoll and 65% Percoll. This layer 
was carefully isolated and washed several times in PBS.  
In order to quantify the amount of neutrophils in this layer, a sample of the cells was stained 
for flow cytometry (see 2.2.5.5). The remaining cells from this layer were used for RNA 
isolation in triplicates, if the flow cytometric analysis showed comparable amounts of 
neutrophils in both wild type and PHD3-/- samples and a neutrophil content of above 80%. 
2.2.5.3 Isolation and cultivation of peritoneal macrophages 
Mature macrophages can be isolated from the peritoneal cavity. This method yields 
comparably little amounts of cells, however, they display a phenotype that resembles 
macrophages in vivo better than BMDM (Zhang et al., 2008). 




8-12 week old mice were killed by cervical dislocation in isoflurane narcosis. A small incision 
was made at the abdomen without harming the peritoneal cavity. The fur was pulled apart to 
uncover the skin lining of the peritoneal cavity. The peritoneal cavity was injected with 4 ml 
0.5% BSA, 2 mM EDTA in PBS using a 26 gauge needle. The abdomen was then massaged 
in order to detach cells. Using a 25 gauge needle, as much fluid as possible was retained 
and collected.  
Cells were spun down at 400 x g for 10 min at 4 °C, resuspended in culture medium and 
plated on 4 petri dishes (35 mm diameter). After 90 min, cells were washed two times with 
PBS in order to remove non-adherent cells. After 48 hrs of cultivation, a sample of the cells 
was analyzed using flow cytometry (see 2.2.5.5). The rest of the cells were harvested for 
RNA isolation if flow cytometric analysis showed more than 80% macrophages.  
2.2.5.4 Flow cytometry of BMDM 
To verify BMDM differentiation and quantify expression of M1 and M2 markers, TNF-R1 and 
2, 350.000 differentiated BMDM were seeded per 35 mm petri dish. Different treatments 
were measured in quadruplicates. Cells were seeded in starvation medium or culture 
medium and kept for 24 hrs in normoxia (20% O2) or hypoxia (1% O2). Treatment with 10
-7 M 
dexamethasone was performed for 18 hrs.  
Cells were detached using 350 µl accutase and transferred into flow cytometry tubes. After 
washing them once in washing buffer, cells were blocked for 15 min using unstained 
CD16/CD32 antibody and then stained according to staining protocol 2 and 3 and measured 
using the FACS Canto II as described above (2.2.3.1). 
2.2.5.5 Flow cytometry of peritoneal macrophages and neutrophils 
The purity of isolated peritoneal macrophages and bone marrow-derived neutrophils was 
analyzed via flow cytometry. 
Around 200.000 peritoneal macrophages were cultured for 48 hrs in 35 mm petri dishes and 
detached using 350 µl accutase. 100.000 neutrophils were taken from the enriched 
neutrophil layer of the Percoll gradient. After washing the cells several times in PBS, 
macrophages and neutrophils were blocked for 15 min using unstained CD16/CD32 antibody 
and then stained according to staining protocol 1 for neutrophils and 2 for peritoneal 
macrophages. Staining and measurement procedures were performed as described above 
(2.2.3.1). 
2.2.5.6 RNA isolation 
RNA was isolated from BMDM seeded in a 6-well at a density of 750.000 cells per well. 
Peritoneal macrophages were seeded at approximately 250.000 cells per 3.5 cm petri dish 
for RNA isolation. RNA was isolated from approximately 1x106 neutrophils. 




RNA was extracted making use of the acid guanidinium thiocyanate-phenol-chloroform 
extraction method (Chomczynski and Sacchi, 1987). In short, the chaotropic guanidinium 
thiocyanate enabled separation of proteins from nucleic acids upon phenol phase separation 
with chloroform.  
Before RNA isolation, macrophages were washed twice in PBS, while neutrophils were 
washed several times in PBS and spun down at 400 x g for 5 min at 4 °C. After removing the 
PBS, cells were lysed in 500 µl TRIzol, which is a commercially available guanidinium 
thiocyanate-phenol mixture. Cell lysates were transferred into e-cups and 200 µl of 
chloroform was added. After mixing the samples shortly on a vortex, they were spun down at 
1200 x g for 15 min at 4 °C to separate the aqueous RNA-containing upper phase from the 
protein-containing organic phase. The upper phase was then mixed with 1 volume of 
isopropanol and incubated at -20 °C for 20 min to precipitate RNA. Neutrophil and peritoneal 
macrophage samples were allowed to incubate over night at -20 °C to increase RNA yield. 
RNA was then pelleted by a centrifugation step at 12000 x g for 20 min at 4 °C and washed 
twice in 750 µl 75% ethanol. After removing the ethanol, pellets were dried, resuspended in 
13 µl autoclaved H2O and incubated for 10 min at 56 °C. RNA quality and concentration were 
determined using a NanoDrop. RNA was stored at -80 °C or directly transcribed into cDNA. 
2.2.5 7 cDNA synthesis 
RNA was transcribed into cDNA using a reverse transcriptase from the Moloney Murine 
Leukemia Virus supplied by the First strand cDNA synthesis kit. In short, 1 µg RNA was 
mixed with Oligo dT (5 µM) primers and incubated at 65 °C for 10 min in order to anneal the 
primers to the RNA. After that, the following substances were added to the sample: 
Table 22: Reaction mix for cDNA synthesis. 
Substance Final concentration 
M-MuLV Reverse Transcriptase  1 U/µl 
RiboLock RNase Inhibitor 1 U/µl 
5x Reaction Buffer 1x 
dNTP Mix 0.5 mM 
 
The reaction mix was then incubated at 37 °C for 60 min in order for the cDNA synthesis to 
take place and at 70 °C for 10 min to inactivate the enzyme. Samples were diluted 1:2 with 
autoclaved H2O and stored at -20 °C or directly used for qRT- PCR. 
2.2.5.8 cDNA synthesis for miRNA 
miRNAs are small non-coding RNAs which are usually around 20-25 bp long. In order to 
study their expression, an adaptor-sequence was ligated into the cDNA to allow for binding of 
a forward and a reverse primer during the following qRT-PCR.  




RNA was isolated from BMDM as described above (2.2.5.6). After that, a treatment with 
DNase was performed to degrade DNA. The following reaction mix was prepared: 
Table 23: Reaction mix for DNase treatment. 
Substance Final concentration 
RNA in RNase-free H2O  
DNase Incubation buffer 1x 
DNase I 0.5 U/µl 
RNase OUT 4 U/µl 
RNase-free H2O Ad 50 µl 
  
Samples were then incubated at 37 °C for 20 min. RNase-free water was added to a final 
volume of 200 µl and the same volume of phenol/chloroform/isoamyl alcohol (24:25:1 
mixture) was added. Samples were vortexed and centrifuged at 13,000 x g for 2 min. The 
upper aqueous phase was transferred into a new cup and RNA was precipitated by 
incubating it in 1 volume isopropanol and 1:10 volume 3 M sodium acetate (pH 4.8) for 
30 min at -20 °C. Samples were spun down at 13000 x g for 30 min at 4 °C, and the 
supernatant was removed. The pellet was washed twice with 75% ethanol, resuspended in 
13 µl RNase-free water and incubated at 56 °C for 10 min. RNA was kept at -80 °C or directly 
used for cDNA synthesis. 
1 µg of RNA was transcribed into cDNA using the All-in-One miRNA First-Strand cDNA 
Synthesis Kit. This kit contains Poly A Polymerase which adds a poly-A tail to 3´-ends of all 
RNAs. Oligo-dT adaptors can then bind to the poly-A tails and the RNA is reversely 
transcribed into cDNA. In short, a reaction mix containing the following ingredients was 
prepared: 
Table 24: Reaction mix for cDNA synthesis out of miRNA. 
Reagent Volume/Final concentration 
RNA 1 µg 
Poly A Polymerase 0.1 U/µl 
RTase Mix 1 µl 
PAP/RT Buffer 1x 
Spike-in control 1 µl 
RNase-free H2O Ad 25 µl 
 
Samples were incubated at 37 °C for 60 min in order to synthesize cDNA and at 85 °C for 
5 min to inactivate the enzymes. Samples were diluted 1:2 with RNase-free H2O and stored 
at -20 °C or directly used for qRT-PCR.  
2.2.5.9 qRT- PCR 
The expression levels of genes can be quantified and compared using quantitative realtime 
polymerase chain reaction (qRT-PCR). During this reaction, transcript amplification is 




detected by the fluorescent dye SYBR green which intercalates with double-stranded DNA. 
Fluorescence intensity directly correlates with transcript abundance and increases with every 
amplification cycle, making it possible to compare expression levels of different genes. The 
SensiMixTM SYBR® Low-ROX kit was used according to the manufacturer´s instructions. In 
short, the following reaction mix was prepared: 
Table 25: Reaction mix for SYBR green qRT-PCR. 
Substance Amount [µl] Final concentration  
SensiMixTM SYBR® Low-ROX kit 12.5 1x 
Primer fw 0.5 0.1 pmol/µl 
Primer rev 0.5 0.1 pmol/µl 
cDNA 1 1:50 
H2O 10.5  
 
For miRNA detection, the Universal Adaptor primer as well as the miRNA-specific primer 
were added in a final concentration of 0.2 µM. The qRT-PCR reaction was run in 96-well 
plates in the Stratagene Mx3000p light cycler following this temperature profile: 
Table 26: Temperature profile for qRT-PCR. 
Step Temperature [°C] Time [min] Cycles 
Initial activation 95 10:00 1 
 
Amplification 
95 00:15  





95 1:00  
1 Annealing temperature 0:30 
95 0:30 
 
The annealing temperatures for the respective genes are given in the primer list (table 7). 
Analysis was done using the MxPro software. CT-values represent the cycle number, at 
which the amplification curve of the respective gene crosses the threshold. CT-values of the 
house keeping gene S12 were subtracted from CT-values of genes of interest to get ΔCT-
values. The mean of the wild type control was then subtracted from these values in order to 
normalize them. ΔΔCT-values were then calculated by inserting normalized ΔCT-values into 
the following formula: 
      
     
The resulting ΔΔCT-values present the fold change of the expression of the gene of interest 
in all samples compared to the wild type control. 




2.2.5.10 Protein isolation 
In order to extract proteins from BMDM, 4x106 cells were seeded in culture medium or 
starvation medium in surface-treated 10 cm dishes for 48 hrs. Cells were incubated in 
normoxia (20% O2) or hypoxia (1% O2) for 24 hrs. After that, cells were washed once in PBS 
and lysed by adding 175 µl cell lysis buffer. Cells were scraped from the dishes and 
incubated in the cell lysis buffer for 10 min on ice. Cell lysates were centrifugated at 
13000 x g for 20 min at 4 °C and the supernatant was collected. Cell lysates were either 
directly processed or stored at -80 °C. 
2.2.5.11 Measuring protein concentration 
Protein concentration in BMDM cell lysates was determined using the Bradford method. In 
short, 1 µl of sample was placed in a 96-well plate and a standard curve was prepared 
ranging from 0.5 µg to 6 µg BSA. 200 µl 1:5 Protein Assay Reagent was added to each well 
and the absorbance at 595 nm was measured in the Bio-Rad Microplate Reader. 80 µg of 
protein per sample was used for Western blot. 
2.2.5.12 SDS-Polyacrylamide gel electrophoresis 
Protein samples were incubated with 1 volume 2xSDS sample buffer for 10 min at 95 °C. 
This sample buffer contains sodium dodecyl sulfate (SDS) which, together with β-
mercaptoethanol, denaturates proteins by disrupting non-covalent bonds. SDS also gives 
proteins a negative charge by associating with them. This allows the separation of proteins 
via an electrical field in the following polyacrylamide gel electrophoresis. Smaller proteins can 
migrate faster through the gel, while bigger proteins are held back by the pores of the 
polyacrylamide-gel, resulting in protein separation according to their size. 
Samples and a PageRuler protein marker were loaded onto a polyacrylamide gel composed 
of a 4% stacking gel, and a 10% or 12% running gel (see table 25). 10% running gels were 
used to obtain Western blots of HIF-1α, while 12% running gels were used for detection of all 
the other proteins. 
Table 27: Composition of stacking and running gels for SDS-polyacrylamide gel electrophoresis. 
Compound 4% stacking gel 10% running gel 12% running gel 
H2O 2.7 ml 11.9 ml 9.9 ml 
30% acrylamide mix 0.67 ml 10 ml 12 ml 
1 M Tris/HCl (pH 6.8) 0.5 ml - - 
1.5 M Tris/HCl (pH 8.8) - 7.5 ml 7.5 ml 
10% SDS 0.04 ml 0.3 ml 0.3 ml 
10% ammonium persulfate 0.04 ml 0.3 ml 0.3 ml 
TEMED 0.004 ml 0.012 ml 0.012 ml 




The SDS-PAGE was run at a constant current of 40-45 mA with a maximum voltage of 
300 V.  
2.2.5.13 Western blot 
Proteins were transferred from the polyacrylamide gel onto a nitrocellulose membrane using 
a semi-dry blotting technique. Again, the negative charge of proteins after association with 
SDS was utilized to ensure transfer. Gel, nitrocellulose membrane and filter paper were 
soaked in Western blot transfer buffer and stacked between the anode and cathode of the 
PerfectBlue Semi-Dry Electroblotter. Negatively charged proteins travelled towards the 
positive anode and were transferred onto the membrane. Western blotting was performed at 
a constant current of 2 mA/cm2 for 1 hr.  
Successful transfer was evaluated by reversibly staining the proteins attached to the 
nitrocellulose membrane in Ponceau S staining solution. Afterwards, the membrane was 
washed in PBS to get rid of the Ponceau staining and incubated in 5% milk for 60 min at 
room temperature to block unspecific binding sites for antibodies.  
The membrane was subsequently incubated in 5% milk containing a primary antibody at the 
dilution listed above (table 5) over night at 4 °C. After that, the membrane was washed three 
times in PBS to get rid of unbound antibodies. The membrane was then incubated in 5 % 
milk containing horseradish peroxidase (HRP)-coupled secondary antibody which would 
recognize the respective primary antibody for 2 hrs at room temperature.  
In order to detect β-actin, the membrane was washed three times and incubated in 10 ml 
enhanced chemiluminescence (ECL) solution, which contains substrates for the horseradish 
peroxidase. The membrane was imaged using the LAS3000 Imager. For all other proteins, a 
commercially available chemiluminescent HRP substrate solution (Merck Millipore) was 
used. X-ray films were exposed to the membrane with varying exposure times to visualize 
protein bands.  
2.2.5.14 Single cell migration 
Migration is a substantial feature of macrophages as they have to migrate into areas of 
inflammation. Migration capacity was measured using a single cell migration approach which 
studied random migration.  
Differentiated BMDM were seeded at a density of 100.000 cells/well in a 6-well. Migration of 
cells was then monitored by taking pictures of an arbitrarily chosen field of interest at a 10x 
magnification. Pictures were taken every 10 min over a period of 6 hrs.  




Images were stacked and cells were tracked using the manual tracking plugin for ImageJ as 
well as the chemotaxis plugin. Cells that wandered out of the field of view were excluded 
from the analysis. 
Cells were either measured in fresh culturing medium as a control condition or in MDA-
MB231-conditioned medium, which presents a migration stimulus.  
In order to create MDA-MB231-conditioned medium, 1x106 MDA-MB231 cells were cultured 
in 10 ml DMEM + 10% FCS and 1% P/S for 4 days. The medium was then spun down at 
4000 rpm for 20 min at 4 °C and the supernatant was stored at -20 °C in aliquots.  
2.2.5.15 Prostaglandin E2 (PGE2) secretion 
Prostaglandin E2 levels were measured using a chemiluminescent ELISA kit. In short, 
endogenous PGE2 competes with PGE2 coupled to alkaline phosphatase (AP) for the 
interaction with a PGE2-specific antibody. This antibody was then caught by a capture 
antibody at the bottom of the well. The chemiluminescence measured upon addition of AP-
substrate inversely correlates with the amount of endogenous PGE2 in the samples. 
Prostaglandin secretion was measured in BMDM supernatant, which was isolated after 
24 hrs of cultivation in normoxia or hypoxia with culture medium or in starvation medium. 
Cells were cultivated at a density of 750.000 per well in 6-well plates. The supernatant was 
removed and centrifuged for 20 min at 12000 x g at 4 °C to pellet floating particles and 
transferred to a new cup. Samples were either used directly or stored at -80 °C. For the 
assay, 100 µl supernatant was used according to the manufacturer´s instructions.  
2.2.5.16 Phagocytotic capacity 
Phagocytotic capacity was measured using labelled latex beads, which emitted red 
fluorescent signals in the acidic environment of the phagosome. In short, BMDMs were 
seeded at a density of 300.000 in a 35 mm petri dish and cultivated for 24 hrs in normoxia or 
hypoxia in normal culture medium or in starvation medium. Treatment with PGE2 was 
performed for 18 hrs at a final concentration of 100 pg/ml. Cells were incubated with latex 
beads for 4 hrs, after which they were detached using 350 µl accutase. Cells were 
centrifuged at 400 x g, washed once with PBS and subsequently analyzed for their uptake of 
beads using the FACS Canto II flow cytometer. Uptake of beads was measured in % 
phagocytotic cells.  
2.2.6 Statistics 
If not indicated otherwise, statistical significance was calculated by using an unpaired two-
tailed student´s T-test. A significant difference between two means was defined by a p-value 







3.1 Characterization of myeloid-specific conditional PHD3 knock out mice 
The goal of the study was to investigate the role of PHD3 in macrophage-mediated 
inflammation after an ischemic insult. In order to dissect macrophage-mediated effects from 
those of other cell types, a mouse model with a myeloid-specific knock out of PHD3 was 
studied. Mice with a heterozygous expression of the cre recombinase under the control of the 
lysozyme M promoter (LysMcre+/-) were crossed with mice that had a floxed PHD3 gene 
(PHD3flox/flox, Figure 4B). This led to excision of exon 2 of PHD3 in cells expressing lysozyme 
M in LysMcre+/-xPHD3flox/flox mice (called PHD3-/- mice hereafter). Lysozyme M is mainly 
expressed in myeloid cells such as macrophages and granulocytes and to a lower degree in 
dendritic cells (Clausen et al., 1999). Mice expressing the floxed PHD3 gene but no cre 
recombinase were used as wild type controls (LysMcre-/-xPHD3flox/flox, called wild type 
hereafter). 
 
Figure 4: Myeloid-specific conditional knock out of PHD3. Mice expressing cre recombinase under 
the control of the lysozyme M promoter were crossed with mice in which exon 2 of the PHD3 locus 









 mice (B), excision of exon 2 took place in myeloid cells. 
I confirmed that indeed both in vitro differentiated BMDM and isolated peritoneal 
macrophages showed a knock out of PHD3 by testing their RNA expression level via qRT-
PCR (Figure 5A) compared to wild type mice. Neutrophils isolated from the bone marrow 
displayed a PHD3 knock out as well. Residual expression of PHD3 in all cell populations 
could be the result of contamination with non-myeloid cells. In case of neutrophils, flow 
cytometry analysis showed that the tested population contained around 80% neutrophils 
(Figure 5C). For peritoneal and bone marrow-derived macrophages, purity was always above 
85% (Figure 5B). Also, an inefficient recombination could be a possible reason why there 
was still a residual PHD3 expression in the PHD3-/- cells. 
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Figure 5: Confirmation of the myeloid knock out of PHD3 on RNA level. (A) RNA expression was 
analyzed in bone marrow-derived macrophages (BMDM), peritoneal macrophages and neutrophils 
relative to the house-keeping gene S12 and normalized to the respective wild type cells. Results are 
representative of at least 3 independent experiments. Neutrophil PHD3 expression levels are 
representative of 2 independent experiments. Bars show mean ± SEM, *** p<0.001. The purity of 
isolated peritoneal macrophages (B) and neutrophils (C) were tested via flow cytometry using the 
markers F4/80 and CD11b (macrophages) or Ly6G and CD11b (neutrophils) for the identification of 
the respective cell population. 
As BMDM yield high enough cell numbers to test protein expression, in contrast to peritoneal 
macrophages and neutrophils, I analyzed HIF-1α, PHD2 and PHD3 protein levels under 
different culture conditions including hypoxia and starvation in a Western blot (Figure 6). 
Fully differentiated BMDM were incubated for 48 hrs in starvation medium or in normal cell 
culture medium. Incubation in hypoxia was performed for 24 hrs. The respective normoxia 
control samples were kept in normoxia for this time. Incubating the cells in hypoxia led to a 
robust HIF-1α stabilization with no apparent difference between wild type and PHD3-/- 
BMDM. In normoxia, HIF-1α is hardly detectable due to its high turnover. Interestingly, knock 
out of PHD3 did not lead to a HIF-1α stabilization in normoxia, suggesting that PHD3 is not 
the main regulator of HIF-1α stability in normoxia. PHD2 protein levels were not upregulated 
in PHD3-/- cells to compensate for the loss of PHD3. 
PHD3 protein levels are hardly detectable in normoxia. The HIF-target gene PHD3 is highly 
upregulated in hypoxia, which leads to a strongly visible band in the wild type sample, while 
the PHD3-/- sample displays only a faint band. Starvation led to a mild HIF-1α stabilization in 











































Figure 6: Confirmation of the knock out of PHD3 in BMDM on protein level. Western blot of 
protein lysates from BMDM was performed. Cells were incubated for 48 hrs in starvation or normal 
culture medium (control) and incubated in hypoxia (1% O2) or normoxia (20% O2) for 24 hrs. Protein 
levels of HIF-1α, PHD2 and PHD3 were studied, β-Actin levels were examined as loading control. 
Results are representative of 3 independent experiments.  
To test whether the myeloid-specific knock out of PHD3 was indeed myeloid-specific, 
different organs were isolated from wild type and PHD3-/- mice. RNA was isolated and tested 
for PHD3 expression. None of the organs of PHD3-/- mice, including the gastrocnemicus 
muscle (GM), heart, skin, spleen, liver, kidney, lung and brain, showed a downregulation of 
PHD3 mRNA (Figure 7), indicating that the myeloid-specific knock out strategy via cre 
expression in lysozyme M-expressing cells does not “leak” to off-target tissues. This is in line 
with an earlier characterization of the myeloid-specific knock out in the LysMcre+ mice 
(Clausen et al., 1999). 
 
Figure 7: Expression of PHD3 in non-myeloid tissues. PHD3 expression was analyzed via qRT-
PCR in different tissues including the gastrocnemicus muscle (GM) isolated from n=3 wild type and 
n=4 PHD3
-/-
 mice and displayed normalized to the respective wild type. Bars show mean ± SEM. 
In summary, the myeloid-specific conditional knock out mouse model shows a clear 





strongly decreased protein levels in BMDM in hypoxia. The fact that HIF-1α protein levels are 
not influenced by the PHD3 knock out is in line with unchanged expression of HIF-target 
genes analyzed earlier in the group of Cardiovascular Physiology (Swain et al., 2014) which 
suggests that HIF-signaling is unchanged in PHD3 knock out BMDM. Analysis of different 
tissues shows no knock out of PHD3 in off-target tissues and suggests a myeloid-specific 
expression of the cre recombinase.  
3.2 Leukocyte infiltration into the ischemic muscle is blunted in PHD3-/- mice 
Members of the PHD enzyme family, especially PHD3 have previously been associated to 
changes in behavior of innate immune cells, such as neutrophils (Walmsley et al., 2011) or 
macrophages (Kiss et al., 2012), where a global PHD3 knock out led to increased 
inflammation in a model of abdominal sepsis. I now wanted to elucidate the role of PHD3 in 
macrophages for ischemia-induced sterile inflammation. 
In order to test for leukocyte infiltration and clearance after hind limb ischemia, mice 
underwent surgery and GMs were isolated on day 1, 3, 4, 5 and 7 after surgery. Muscles 
were digested and tissue lysates were stained for markers of different subpopulations, such 
as macrophages (F4/80+ CD11b+) and neutrophils (Ly6G+ CD11b+), as well as for markers of 
macrophage polarization (CD86, CD206).  
Analyzing leukocyte numbers (Figure 8A) via CD11b surface expression revealed that 
inflammation in the GM peaks around day 4 and is mostly cleared away at day 7. On day 4 
and 5, a significantly lower number of infiltrating leukocytes were found in the myeloid-
specific PHD3 knock out compared to wild type controls.  
 
Figure 8: Leukocyte infiltration in the ischemic muscle after hind limb ischemia in PHD3
-/-
 mice. 
Leukocyte infiltration was analyzed via flow cytometry over the course of 7 days after surgery within 
the gastrocnemicus muscle. Cell populations are displayed as % of total cell population within the 
tissue lysates of unligated and ligated legs of wild type and PHD3
-/-
 mice. (A) Leukocytes were 
identified as CD11b
+
 cells. (B) Exemplary histogram of CD11b
 
expression within the cell population 
isolated from a wild type (black line) and a PHD3
-/-
 (red line) mouse 4 days after surgery. In total, the 
following numbers of mice were analyzed per group: day 1 wild type=6, PHD3
-/-
=7, day 3 wild type=5, 
PHD3
-/-
=8, day 4 wild type=15, PHD3
-/-
=15, day 5 wild type=7, PHD3
-/-
=6, day 7 wild type=6, PHD3
-/-
















































The leukocyte population which is responsible for the blunted inflammatory phenotype 
seemed to be macrophages, which were first detectable 3 days after surgery. At this time 
point wild type and PHD3-/- macrophages were still abundant at similar levels. At day 4 and 5 
however, PHD3-/- macrophages were present at significantly lower numbers compared to wild 
type macrophages (Figure 9).  
 
Figure 9: Macrophage infiltration in the ischemic muscle after hind limb ischemia in PHD3
-/-
 
mice. Macrophage infiltration was analyzed via flow cytometry over the course of 7 days after surgery 




 cells. (B) 
Density plots are shown of an exemplary wild type (left graph) and PHD3
-/-
 (right graph) sample 4 days 
after surgery. In total, the following numbers of mice were analyzed per group: day 1 wild type=6, 
PHD3
-/-
=7, day 3 wild type=5, PHD3
-/-
=8, day 4 wild type=15, PHD3
-/-
=15, day 5 wild type=7, PHD3
-/-
=6, day 7 wild type=6, PHD3
-/-
=8 mice. Graph (A) represents mean ± SEM (* p<0.05, ** p<0.01). 
To analyze whether the macrophage reaction was blunted due to a secondary effect caused 
by neutrophils, this cell population was also studied (Figure 10). Neutrophil levels did not 
show any significant difference on day 1 or day 3 after surgery, which present the main days 
of their presence within the ischemic muscle tissue.  
 
Figure 10: Neutrophil infiltration in the ischemic muscle after hind limb ischemia in PHD3
-/-
 






 cells. In total, the following numbers of 
mice were analyzed per group: day 1 wild type=6, PHD3
-/-
=7, day 3 wild type=5, PHD3
-/-
=8, day 4 wild 
type=15, PHD3
-/-
=15, day 5 wild type=7, PHD3
-/-
=6, day 7 wild type=6, PHD3
-/-
=8 mice. Graph 











































The macrophage population was additionally analyzed regarding their expression of pro-
inflammatory (M1) or anti-inflammatory (M2) markers. CD86 was used as a marker for M1-
polarization while CD206 was used as a marker for M2-polarization. CD86 levels within the 
macrophage population did not change significantly between wild type and PHD3-/- (Figure 
11A and 11C). CD206 levels, however, showed a clear induction from day 3 to day 4 and 5, 
indicating that wound healing processes are already being induced in this stage (Figure 11B 
and 11D). PHD3-/- macrophages, compared to macrophages from wild type littermates, 
displayed a higher expression of CD206 both at day 4 and at day 5.  
 
Figure 11: Macrophage polarization in PHD3
-/-
 mice. Macrophage polarization was analyzed via 
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 macrophage population. Exemplary histograms are shown for one wild type (black line) and 
one PHD3
-/-
 (red line) mouse (C and D). In total, the following numbers of mice were analyzed per 
group: day 1 wild type=6, PHD3
-/-
=7, day 3 wild type=5, PHD3
-/-
=8, day 4 wild type=15, PHD3
-/-
=15, 
day 5 wild type=7, PHD3
-/-
=6, day 7 wild type=6, PHD3
-/-
=8 mice. Bars represent mean ± SEM 
(* p<0.05, ** p<0.01). 
Taken together, these data suggest a blunted inflammatory response in the ischemic muscle 
after hind limb ischemia caused mainly by the macrophage population in myeloid-specific 
PHD3-/- mice. A more anti-inflammatory polarization, as suggested by the expression levels 































































































3.3 Cytokine levels in the blood are unchanged between wild type and PHD3-/- mice 
after hind limb ischemia 
Strong inflammatory reactions result in cytokine secretion by immune cells to the blood 
stream. In order to test whether plasma cytokines levels are elevated after hind limb 
ischemia, peripheral blood was taken 1, 3, 5 or 7 days after surgery, covering the whole time 
period of the inflammatory reaction in the hind limb muscle.  
Plasma was isolated from wild type and PHD3-/- blood and tested using a cytometric bead 
assay to analyze concentrations of the cytokines IL-6 (Figure 12A), MCP-1 (Figure 12B) and 
TNF (Figure 12C). As a reference, plasma from resting age and gender-matched mice was 
used. IL-6 showed a clear increase in concentration 1 day after surgery as well as elevated 
levels on day 3 and 5 after surgery, however, there was no difference visible between wild 
type and PHD3-/- mice. Also, TNF and MCP-1 levels showed slightly increased cytokine 
concentrations after surgery compared to the resting control, though standard deviations 
were quite high. They however also did not show a significant difference between plasma 
concentrations of wild type and PHD3-/- mice. Of note, cytokine concentrations were in 
general rather low, which implies that the inflammatory reaction was well defined to the 
ischemic muscle with rather little systemic impact. 
  
Figure 12: Plasma concentration of pro-inflammatory cytokines of wild type and PHD3
-/-
 mice. 
IL-6 (A), MCP-1 (B) and TNF (C) concentration [pg/ml] in plasma of resting control mice as well as 1, 
3, 5 and 7 days after hind limb ischemia surgery were measured using a cytometric bead assay. The 
following numbers of mice were used per group: control wild type=5, PHD3
-/-
=4, day 1 and 3 n=6 for all 
groups, day 5 and 7 wild type=6, PHD3
-/-
=5. Bars represent mean ± SEM. P<0.05 # (comparing 





3.4 Reperfusion recovery stays unchanged between wild type and PHD3-/- mice 
Macrophages are not only important for the early phases of inflammation, they also mediate 
wound healing processes like angiogenesis and arteriogenesis. To investigate, whether a 
knock out of PHD3 influences the properties of macrophages responsible for these aspects, I 
analyzed perfusion recovery after hind limb ischemia surgery measured via laser Doppler 
imaging (Figure 13A and B).  
Mice underwent hind limb ischemia surgery and were analyzed before, directly after as well 
as on day 1, 3, 5, 7, 14, 21 and 28 after surgery. Both wild type and PHD3-/- mice showed 
after an initial sharp drop a steep increase of perfusion within 7 days. Perfusion recovered up 
to 70-80% until day 28. There was no significant difference in perfusion recovery at any of 
the investigated time points between the two groups. In addition, the development of necrotic 
toe nails, which is an indicator for insufficient paw perfusion, was analyzed. Toe nails of a 
small number of mice were stained black around day 2 after surgery (Figure 13C). This was 
a non-reversible effect that did not impair foot or limb movement and was closely monitored. 
The number of necrotic toe nails per paw was documented and it was quantified how many 
of the mice per genotype developed 1, 2, 3, 4 or 5 black toe nails on the paw of the operated 
leg. There was no significant difference between wild type and PHD3-/- mice to whether they 
developed necrotic toes or not.  
 
Figure 13: Perfusion recovery after hind limb ischemia in wild type and PHD3
-/-
 mice. (A) 
Perfusion was measured from laser Doppler images before, directly after and 1, 3, 5, 7, 14, 21 and 28 
days after surgery. Perfusion was measured as signal intensities per image and normalized to the 
value of the unligated leg of each animal. Groups included day 0 wild type=32, day 0 PHD3
-/-
=32, day 
1 wild type=13, day 1 PHD3
-/-
=18, day 3 wild type=23, day 3 PHD3
-/-







=22, day 7 wild type=7, day 7 PHD3
-/-
=15, day 14, 21, 28 wild type=7, PHD3
-/-
=7 mice. Graph 
shows mean ± SEM. (B) Exemplary images of laser Doppler measurements are depicted, color code 
represents the amount of perfusion measured (arbitrary intensity units). (C) Number of necrotic toe 
nails counted per paw per animal comparing wild type and PHD3
-/-
 mice.  
Taken together, these results suggest that processes leading to perfusion recovery are not 
differentially influenced by PHD3-/- macrophages as there was no significant difference in 
perfusion recovery nor in development of necrotic toes. 
 
3.5 Angiogenesis after hind limb ischemia is unchanged between wild type and PHD3-/- 
mice 
The acquired perfusion data suggest that processes like angiogenesis and arteriogenesis are 
not altered by a myeloid-specific knock out of PHD3. This result deviates from previously 
published data in a global PHD3 knock out, where PHD3-/- mice had an ameliorated 
perfusion recovery after hind limb ischemia (Rishi et al., 2015). Therefore I wanted to confirm 
my finding with an independent method. The model of hind limb ischemia applied here leads 
to a permanent ligation of the femoral artery, and additionally ligates one main branch of the 
artery which could be used as a collateral for arteriogenesis, the proximal caudal femoral 
artery. Therefore, possible arteriogenic effects are highly limited by this surgery technique 
and thus were not studied in depth. 
I chose to evaluate angiogenesis on cryosections of GM. Mice underwent hind limb ischemia 
and after 3 or 28 days, muscles were extracted. Blood vessels such as capillaries were 
visualized via isolectin IB4 staining. The extent of angiogenesis was quantified by analyzing 
average capillary size (Figure 14A) and capillary number (Figure 14B) in relation to the 
number of muscle cells.  
Both at day 3 and day 28 the number of capillaries and their average size were significantly 
increased in ligated legs of both groups compared to their unligated controls, indicating that 
the applied analysis technique was able to detect angiogenic effects. However, no significant 
difference could be observed when comparing wild type and PHD3-/- mice, neither in the 







Figure 14: Angiogenesis in PHD3
-/-
 mice after hind limb ischemia. Angiogenesis was analyzed on 
cryosections of the gastrocnemicus muscle (GM) 3 and 28 days after hind limb ischemia surgery in 
unligated and ligated legs. Average size (A) and capillary number per muscle cells (B) were analyzed 
using ImageJ. Groups include for day 3 wild type = 5, PHD3
-/- 
= 7 mice and for day 28 7 mice per 
group. Bars present mean ± SEM, * p<0.05, ** p<0.01, *** p<0,001. Exemplary images of stained 
sections on day 3 and 28 for the unligated and ligated leg are displayed in (C). Capillaries are 
visualized by Isolectin IB4, while muscle cells were detected with an antibody against vinculin and cell 
nuclei were stained with Hoechst. Scale bars represent 50 µm. 
In conclusion, no differences towards angiogenic effects were observed between wild type 
and PHD3-/- mice. This finding is in line with the above shown perfusion data. 
 
3.6 Fibrotic processes are inhibited in PHD3-/- mice while motor function is unaltered 
after hind limb ischemia 
The course of a sterile inflammation can influence processes like wound healing strongly. 
Fibrosis, which is characterized by an excessive production of extracellular matrix proteins by 
activated fibroblasts, can be the result of a prolonged inflammatory reaction of the tissue. 
Also, the effectiveness of wound healing can have a direct influence on organ performance, 
in case of the leg for example in running performance. 
In order to test, whether the decreased inflammatory reaction towards hind limb ischemia in 





mice underwent hind limb ischemia and were examined until day 28 towards impairment of 
their motor function. At day 28, GM were extracted and the amount of fibrosis was quantified 
via picro-sirius red staining on tissue sections. 
Quantification of picro-sirius red-positive area on tissue sections of ligated and unligated legs 
revealed a higher content of fibrotic tissue in wild type mice compared to PHD3-/- (Figure 
15A, B). GM of ligated legs from PHD3-/- mice showed only a mild increase in comparison to 
the unligated leg. This suggests that fibrotic processes are inhibited in PHD3-/- mice.  
 
Figure 15: Fibrosis quantification on tissue sections of PHD3
-/-
 mice. Fibrosis was quantified via 
picro-sirius red staining of hind limb muscles 28 days after surgery. (A) Sections of 3 different areas of 
the hind limb muscle were stained with picro-sirius red and the whole tissue section was imaged in a 
20x magnification. Quantification of the picro-sirius red area per tissue region was performed using 
ImageJ. Groups of 7 wild type and 7 PHD3
-/-
 mice were analyzed. Bars show mean ± SEM, * p<0.05 
*** p<0.001. (B) Exemplary pictures of a wild type and a PHD3
-/-
 ligated hind limb muscle in 20x 
magnification. Scale bar represents 200 µm.  
Motor function in mice was assessed in order to see whether the change in the course of 
inflammation impacts on a clinical parameter such as the ability to move the leg and foot 
after surgery. Mice were graded according to a grading system adapted from (Rishi et al., 
2015). In detail, the ability to move the limb was graded in 5 scores: 5 for no impairment, 4 
for mice who frequently adopted a relieving posture, 3 for mice that made a claw, 2 for mice 
that could not move the foot, 1 for mice that could not move the whole limb. The grading was 
performed during the first week after surgery (Figure 16). In most mice, impairment was only 
clearly visible within the first days after surgery. Until day 7, all mice had recovered their 
abilities to move their foot to a degree where no impairment was visible anymore. Overall, no 






Figure 16: Motor function after surgery analyzed via a grading system. Motor function was 
analyzed via a grading system (5=no impairment, 4=relieving posture, 3=making a claw, 2=not able to 
move the foot, 1=not able to move the limb) within the first 7 days after hind limb ischemia surgery. 
Groups include wild type=13 and PHD3
-/-
=12 mice. Graph shows mean ± SEM. 
Motor function was additionally determined using a RotaRod system (Figure 17). 
Performance was measured before and up to 27 days after surgery. Mice showed a mild 
drop of performance, measured as maximum speed, 2 days after the surgery, from which 
they partially recovered. Until day 28, the performance of mice decreased slightly. In order to 
see whether this was caused by the surgery or just an aging or learning effect, a resting age 
and gender-matched group of mice underwent the same setup until day 21. Control mice 
performed significantly better on day 14 and 21 compared to wild type (only day 14) or PHD3-
/- mice, which indicates that the decrease of performance is indeed due to the surgery. There 
was no significant difference between wild type and PHD3-/- mice at any of the time points. 
However, the individual performances, partially influenced by mouse behavior, strongly 
varied within wild type and PHD3-/- groups.  
 
Figure 17: Motor function after surgery analyzed via a running test. Motor function was analyzed 
via the maximum speed mice ran on a RotaRod. Analysis includes co=5 (resting control mice), wild 
type=7 and PHD3
-/-
=7 mice. Graph shows mean ± SEM, */#/§ p<0.05; **/##/§§ p<0.01; 
***/###/§§§p<0.001. * shows significance between wild type pre value and the value of the respective 
day. § shows significance between the control group and wild type group at the respective day. # 
shows significance between the control group and PHD3
-/-





In summary, the absence of a difference in motor function between wild type and PHD3-/- 
groups could either be the result of high variation between the mice or by a rather mild effect 
on wound healing which did not translate into a detectable better outcome of running 
performance.  
 
3.7 Analysis of cell death and migration in PHD3-/- macrophages 
The observed blunted inflammatory reaction of macrophages in PHD3-/- mice after hind limb 
ischemia surgery could be caused by a differential behavior of the macrophages. I 
hypothesized that it could be either caused by a migratory phenotype that impairs their 
further migration into the tissue at later days, or by an apoptosis phenotype. 
In a previous study (Swain et al., 2014), the group of Cardiovascular Physiology could show 
that under stress conditions such as serum deprivation and treatment with pro-apoptotic 
factors, PHD3-/- BMDM are protected against apoptosis. In order to investigate apoptosis and 
cell death of tissue macrophages after hind limb ischemia, lysates of hind limb muscles 
underwent flow cytometric analysis to characterize the macrophage population (Figure 18A). 
The lysates were stained with a live-dead marker (Zombie green) and Annexin V, which 
identifies apoptotic cells (Figure 18B). Within the macrophage population, the intensities for 
Zombie green and Annexin V were analyzed to differentiate between living, early and late 
apoptotic as well as dead cells according to their staining. In total, there was no difference in 
the relative amount of living, early apoptotic, late apoptotic or dead cells between wild type 
and PHD3-/- samples (Figure 18C), suggesting that cell death of macrophages is not involved 
in the blunted inflammation after hind limb ischemia surgery. 
 
Figure 18: Apoptosis rates in PHD3
-/-
 macrophages isolated from the gastrocnemicus muscle. 
Cell death was analyzed within the macrophage population on day 4 after surgery. (A) Macrophages 


















). Gates were set using FMO 
(fluorescence minus one) controls. (C) Analysis of macrophage population of wild type and PHD3
-/-
 
mice, differentiating between live, early and late apoptotic and dead cells. Bars represent 
mean ± SEM. The groups represent wild type=6, PHD3
-/-










































In order to test migration as a potential cause for a change in inflammation, peritoneal 
macrophages (PM) as well as BMDMs from wild type and PHD3-/- mice were studied. Cells 
were seeded at a low density and pictures were taken every 10 min for a period of 6 hrs. The 
average accumulated distance that the cells covered during this time was measured via 
ImageJ. During this time, cells were either kept in normal culture medium (FCS) or in MDA-
MB231-conditioned medium, which serves as a migratory stimulus. No difference in 
migration was observed between wild type and PHD3-/- cells neither in normal culture 
medium nor in MDA-MB231-conditioned medium (Figure 19). 
 
Figure 19: Cell migration in wild type and PHD3
-/-
 BMDM and PM. Migration of BMDM (A) and 
peritoneal macrophages (PM, B) was analyzed using a single cell migration assay. Images were made 
every 10 min over a time period of 6 hrs and accumulated distance was calculated using ImageJ. 
During the time of image acquisition, cells were kept in normoxia, either in normal culture medium 
(FCS) or in MDA-MB231-conditioned medium to stimulate migration. Results are representative for 3 
independent experiments. Bars show mean ± SEM, *** p<0.001. 
In summary, both apoptosis and migration do not seem to mediate the blunted macrophage 
inflammatory reaction in PHD3-/- mice. 
 
3.8 RNA sequencing of sorted macrophages reveal 10 differentially regulated genes 
between PHD3-/- and wild type mice 
Previous data from an unbiased transcriptome screen in BMDM from PHD3-/- and wild type 
control mice could not show any differentially regulated genes when cells were cultured in 
culture medium in normoxia or hypoxia for 48 hrs (Swain et al., 2014). As BMDM are a 
limited model to study macrophage behavior in ischemic inflammatory situations like hind 
limb ischemia, I decided to isolate macrophages from hind limb muscles after hind limb 
ischemia surgery. As the peak of the inflammation on day 4 showed a high standard 
deviation (Figure 9), I chose to isolate macrophages from the tissue on day 5 after the 
surgery, where the individual differences in inflammation are less prominent in both wild type 





lysates and isolated RNA for sequencing, which was performed with the help of the 
transcriptome analysis lab (TAL, UMG Göttingen). 
Between 5000 and 50000 macrophages were successfully isolated from each muscle (Figure 
20).  
 
Figure 20: Macrophage count of samples used for RNA sequencing. Macrophages were sorted 
from the gastrocnemicus muscle (GM) 5 days after surgery. In total, sorted macrophages from 5 wild 
type and 5 PHD3
-/-
 mice were used. Graph displays mean ± SEM. 
Due to the low amount of macrophages, a DNase treatment of the isolated RNA was not 
possible prior to cDNA library preparation. This caused a considerable DNA contamination 
within the samples that might have influenced the outcome of this experiment. In addition, 2 
of the samples handed in showed a high contamination rate with bacterial and viral DNA. 
Both samples were excluded from the analysis resulting in the comparison of 3 wild type and 
5 PHD3-/- samples. In total, 10 candidate genes were successfully identified to be 
significantly regulated between wild type and PHD3-/- macrophages.  
Among the significantly regulated genes there are 4 that are upregulated (Figure 21): 
Lysozyme 1, miR-511, the Ensembl gene ENSMUSG00000063254 as well as RNA binding 
motif protein 4 (Rbm4). The microRNA miR-511 was recently associated with anti-
inflammatory properties in a mouse model of septic shock (Puimege et al., 2015). Rbm4 can 
form a complex with Argonaute-2 and specifically degrade mRNA of IL-6 and TNF-α 
(Brudecki et al., 2013). An upregulation of Rbm4 could therefore potentially lead to less IL-6 
or TNF-α mRNA. However, both IL-6 and TNF-α mRNAs were not downregulated in our 
screen. ENSMUSG00000063254 is a transcript for which no function has been described 
yet. 
In total, 6 genes were found to be significantly downregulated in this screen. Among those 
identified is Lysozyme 2, which could be explained by the knock out strategy of the PHD3-/- 
mice that express cre recombinase under the control of the Lysozyme 2 (also called 
Lysozyme M) promoter. This could interfere with endogenous Lysozyme 2 expression and 





macrophages to retain enough Lysozyme. Other downregulated genes include pleckstrin 
homology like domain family A member 3 (Phlda3), Collagen type 8 alpha 1, the predicted 
genes GM23153 and GM22567 as well as Cytochrome P450 family 2 subfamily S member 1 
(Cyp2s1). Among these candidates, the only one directly associated with inflammation is 
Cyp2s1. This cytochrome P450 epoxygenase was found to be highly expressed in pro-
inflammatory M1-macrophages and in inflammatory settings such as atherosclerosis (Fromel 
et al., 2013). The biologic function of Cyp2s1 has been described to be catalyzing the 
reaction of prostaglandin G2 and H2 (PG2, PH2) to 12-Hydroxyheptadecatrenoic acid (12-
HHT). PGG2 and PGH2 can also serve as substrates for prostaglandin E2 (PGE2)-
production. PGE2 is a potent inflammatory regulator which has been shown to induce M2-
polarization in macrophages and inhibit the NLRP3 inflammasome (Sokolowska et al., 2015; 
Strassmann et al., 1994).  
  
Figure 21: Heatmap of a RNA sequencing screen using macrophages sorted from the hind limb 
tissue 5 days after surgery. Macrophages from 3 wild type and 5 PHD3
-/-
 mice were analyzed. The 
heatmap displays the genes that were differentially regulated with a log2 fold change of ±1 in PHD3
-/-
 
macrophages compared to wild type. 
To conclude, the RNA sequencing underwent some technical difficulties, however also 
provided 10 significantly regulated genes. Out of those, especially miR-511, as well as Rbm4 
and Cyp2s1 present promising targets.  
To confirm the differential expression of the regulated genes for miR-511, Cyp2s1 and 
Rbm4, RNA was isolated from macrophages of an independent set of wild type and PHD3-/- 






























was studied via qRT-PCR (Figure 22). miR-511 has two mature sequences, miR-511-3p and 
5p. The expression of both of them was analyzed via qRT-PCR as well.  
The miR-511 sequences miR-511-3p and miR-511-5p were found to be equally- though in 
the case of miR-511-5p not significantly- upregulated which confirms the upregulation 
observed in the RNA sequencing analysis. Cyp2s1 showed a distinct but not significant 
downregulation in PHD3-/- macrophages compared to wild type cells which was also in line 
with the RNA sequencing analysis. PHD3 was also less expressed in PHD3-/- compared to 
wild type macrophages though not in a significant way. Rbm4, which was significantly 
upregulated in the RNA sequencing results, was slightly downregulated in this experiment.  
 
Figure 22: Confirmation of the RNA sequencing results in macrophages sorted from the 
gastrocnemicus muscle 5 days after hind limb ischemia. Macrophages from n=4 wild type and 
PHD3
-/-
 mice were sorted and RNA expression of miR-511-3p and miR-511-5p was analyzed via qRT-
PCR. RNA expression was normalized to the house-keeper U6 snRNA. Macrophages from n=5 wild 
type and n=4 PHD3
-/-
 mice were sorted and RNA expression of Rbm4, PHD3 and Cyp2s1 was 
analyzed via qRT-PCR. The RNA expression was normalized to the house-keeping gene S12. Graphs 
show mean ± SEM, * p<0.05, p-values higher than 0.05 are indicated. 
In summary, both miR-511 and Cyp2s1 expression showed marked though not significant 
regulation, which confirms the RNA sequencing results. PHD3 was non-significantly 
downregulated which was already the case in the RNA sequencing. The RNA sequencing 
result of Rbm4 could however not be confirmed. To see whether these results could also be 







3.9 miR-511 expression and TNF-R1 levels in macrophages 
miR-511 is one of the 10 significantly regulated genes in PHD3-/- macrophages identified by a 
RNA sequencing approach. miR-511 has previously been shown to downregulate TNF-R1 
expression (Puimege et al., 2015), which decreased the inflammatory reaction in a model of 
septic shock. I hypothesized that miR-511 upregulation could mediate a similar phenotype in 
PHD3-/- macrophages, potentially causing the decrease in inflammation observed after hind 
limb ischemia. As miR-511 has been shown to be transcriptionally regulated by the 
glucocorticoid receptor (GR), I additionally treated BMDM with dexamethasone, a steroid 
which can bind the GR, in order to stimulate miR-511 expression. 
I tested TNF-R1 expression on macrophages isolated from hind limb muscles 4 days after 
hind limb ischemia surgery (Figure 23A). I observed a slight but not significant decrease of 
TNF-R1 expression on PHD3-/- macrophages compared to cells isolated from wild type 
littermates. In order to see whether this was a general effect, expression of the TNF-R 
isoform TNF-R2 was tested as well (Figure 23B). TNF-R2 levels also slightly decreased, 
although this protein has not been reported to be a miR-511 target.  
I next tested miR-511 expression in BMDM to see whether I could confirm a differential 
expression of it in a cell culture model (Figure 23C and D). As normal culture conditions did 
not reveal any changes in expression between wild type and PHD3-/- BMDM in a previous 
transcriptome screen (Swain et al., 2014), I cultured the cells in normal and in starvation 
medium in normoxia as well as hypoxia, to mimic the in vivo ischemic conditions. 
Additionally, I treated cells with dexamethasone to increase miR-511 transcription. However, 
none of the tested conditions revealed a significant upregulation of miR-511-3p or -5p, the 






Figure 23: TNF-R1 and miR-511 expression in PHD3
-/-
 macrophages. Flow cytometric analysis of 




 macrophage population isolated from the 
GM 4 days after surgery. The experiment includes wild type=8 and PHD3
-/-
=8 mice. Graphs represent 
the geometric mean fluorescence intensity for each marker as mean ± SEM. Expression analysis via 
qRT-PCR of the two mature miR-511 sequences miR-511-3p (C) and -5p (D) in BMDM. Cells were 
cultured for 24 hrs in normoxia (20% O2) or hypoxia (1% O2) in normal culture medium (co) or in 
starvation medium (starv). Dexamethasone was added in a final concentration of 10
-7 
M for 18 hrs. 
Bars show mean ± SEM, * p<0.05, ** p<0.01. Experiment is representable for three independent 
experiments. 
In conclusion, a differential regulation of miR-511 could not be mimicked in vitro, and TNF-R1 
expression on macrophages in vivo did not reveal any significant difference which indicates 
that there is no relevant influence of miR-511 on the inflammatory reaction, at least not via 
TNF-R1. 
3.10 Cyp2s1 expression is downregulated in PHD3-/- BMDM 
Cyp2s1 is one of the candidates of the RNA sequencing which was significantly 
downregulated in PHD3-/- macrophages sorted from the ischemic tissue. The function of 
Cyp2s1 is only partially understood. In macrophages, Cyp2s1 is responsible for catalyzing 
the reaction of prostaglandin G2 and H2 to 12-HHT (Fromel et al., 2013), an agonist for the 
leukotriene B4 receptor 2 (BLT2) (Liu et al., 2014). Apart from that, Cyp2s1 is highly 
inducible by pro-inflammatory cytokines such as IFN-ɣ and LPS, which is why it is proclaimed 





As the RNA sequencing data suggested a downregulation of Cyp2s1 in PHD3-/- 
macrophages, I analyzed in BMDM whether Cyp2s1 was indeed downregulated on RNA 
level and whether this coincided with an anti-inflammatory phenotype based on the 
expression of pro-inflammatory cytokines such as TNF-α, IL-6 and IL-12b (Figure 24). In 
order to mimic the ischemic situation after hind limb ischemia in vitro, I cultivated BMDM for 
24 hrs in normoxia or hypoxia in normal culture medium or starvation medium. Cyp2s1 was 
significantly downregulated in hypoxia combined with starvation, however, the expression of 
pro-inflammatory cytokines did not indicate a different polarization between wild type and 
PHD3-/- BMDM in these conditions. 
 
Figure 24: Cyp2s1 is downregulated in PHD3
-/-
 BMDM. The RNA expression of Cyp2s1 (A), TNF-α 
(B), IL-12b (C) and IL-6 (D) was analyzed via qRT-PCR. Cells were either incubated for 24 hrs in 
normoxia (1% O2) or hypoxia (20% O2) and either in normal culture conditions (co) or in starvation 
medium (starv) for 24 hrs. Values were normalized to the wild type 20% O2 control sample. Bars show 
the mean ± SEM with * p<0.05, ** p<0.01, *** p<0.001. Graphs are representative for n=3 independent 
experiments. 
In summary, the downregulation of Cyp2s1 in sorted PHD3-/- macrophages identified in a 
RNA sequencing could be mimicked in PHD3-/- BMDM when cultured in starvation medium in 
hypoxia. However, this downregulation was not an indicator for a downregulation of pro-





3.11 Prostaglandin E2 secretion is upregulated in PHD3-/- BMDM 
Cyp2s1 utilizes prostaglandin (PG) G2 and H2 as substrates for 12-HHT production. PGG2 
and PGH2 also serve as a substrate for PGE2 synthesis. By spending the starting material 
for PGE2 synthesis for 12-HHT synthesis, Cyp2s1 could potentially be able to limit PGE2 
synthesis. PGE2 is a potent mediator of inflammation, which can prime macrophages 
towards M2-poarization (Strassmann et al., 1994). The observed downregulation of Cyp2s1 
in PHD3-/- macrophages might therefore lead to increased PGE2 levels, as more substrates 
are present for PGE2 synthesis. 
I therefore tested PGE2 secretion by performing an ELISA on cell culture supernatants of 
PHD3-/- and wild type BMDM cultivated in hypoxia in normal or starvation medium (Figure 
25). While there was no apparent difference in normal culture medium, PHD3-/- BMDM 
secreted significantly more PGE2 compared to wild type BMDM when incubated in starvation 
medium. 
 
Figure 25: Prostaglandin E2 (PGE2) secretion is upregulated in PHD3
-/-
 BMDM. PGE2 levels were 
measured with an ELISA in the supernatant of PHD3
-/-
 and wild type BMDM incubated in hypoxia 
(24 hrs) in normal culture medium (co) or in starvation medium (starv). The displayed results are 
representative for n=3 experiments. Bars show mean ± SEM with * p<0.05, **<0.01. 
The increased PGE2 secretion of PHD3-/- BMDM in hypoxia and starvation correlates with 
the downregulated Cyp2s1 expression observed in these culture conditions. While Cyp2s1 
was not regulated in hypoxia in normal culture medium, PGE2 secretion was also not altered. 
Increased PGE2 secretion could be a possible explanation for the blunted inflammatory 
reaction of macrophages after hind limb ischemia, as Cyp2s1 levels were also found to be 
significantly downregulated in isolated macrophages from hind limb muscles. 
3.12 Phagocytosis in enhanced in PHD3-/- BMDM 
As downregulation of Cyp2s1 has been described to induce an increase in phagocytotic 





capacity was differentially regulated between wild type and PHD3-/- BMDM in the different 
culture conditions. In addition, I studied whether the addition of 100 pg/ml PGE2 could 
increase phagocytosis. This concentration was chosen as it reflects the difference in PGE2 
secretion between wild type and PHD3-/- BMDM in starvation and hypoxia.  
BMDMs were cultivated normal culture medium or starvation medium in normoxia or hypoxia 
for 24 hrs (Figure 26). Treatment with PGE2 was performed for 18 hrs. The macrophages 
were treated with latex beads for 4 hrs, which emitted fluorescence upon phagocytosis. The 
percentage of phagocytotic macrophages showed no difference in normal culture medium. In 
starvation medium however, PHD3-/- macrophages showed a higher phagocytosis rate 
compared to wild type. This effect was independent from incubation in normoxia or hypoxia. 
Treatment with PGE2 did not change phagocytosis in macrophages cultivated in normal 
culture medium. In starvation medium, both wild type and PHD3-/- macrophages showed a 
higher phagocytosis rate upon PGE2 treatment compared to untreated controls. Interestingly, 
the addition of 100 pg/ml PGE2 to wild type cells in starvation elevated phagocytosis rates to 
approximately the level of PHD3-/- macrophages without treatment. 
 
Figure 26: Phagocytosis is elevated in PHD3
-/-
 macrophages upon starvation. PHD3
-/-
 and wild 
type BMDMs were cultivated in starvation (starv) or normal culture medium (co) in hypoxia or 
normoxia for 24 hrs and treated with PGE2 for 18 hrs. Phagocytotic capacity was measured via flow 
cytometry based on the uptake of latex beads. The displayed data are representative for two 
independent experiments. Bars show mean ± SEM with * p<0.05, ** p<0.01, *** p<0.001.  
This data suggest that a differential PGE2 secretion might mediate a change in macrophage 
behavior, leading to increased phagocytosis rates in PHD3-/- macrophages. Phagocytosis is a 
vital process for the swift clearance of apoptotic neutrophils and cell debris and therefore for 
the resolution of sterile inflammation. A more efficient phagocytosis might lessen the 
recruitment of monocytes from the blood stream to the tissue in the setting of hind limb 
ischemia. By this mechanism, the decreased inflammatory response of PHD3-/- macrophages 





3.13 Myeloid-specific conditional knock out mouse model for PHD2 
A downregulation of PHD2 shifts macrophage metabolism towards anaerobic glycolysis, 
which is associated with impaired macrophage migration and phagocytosis in vitro (Güntsch 
et al., in revision). In order to evaluate the effects of PHD2 deficiency in macrophages in vivo, 
mice with a myeloid-specific conditional knock out of PHD2 were studied.  
Mice with a heterozygous expression of cre recombinase under the control of lysozyme M 
promoter (LysMcre+/-) were crossed with mice that had a floxed PHD2 gene (PHD2flox/flox, 
Figure 27B). This led to excision of exon 2 and 3 in cells expressing lysozyme M in 
LysMcre+/-xPHD2flox/flox mice (called PHD2-/- mice hereafter). Mice expressing the floxed 
PHD2 gene but no cre recombinase were used as wild type controls (LysMcre-/-xPHD2flox/flox, 
called wild type hereafter, Figure 27A). Lysozyme M is mainly expressed in myeloid cells 
such as macrophages and granulocytes and to a lower degree in dendritic cells (Clausen et 
al., 1999).  
 
Figure 27: Myeloid-specific conditional knock out of PHD2. Mice expressing cre recombinase 
under the control of the Lysozyme M promoter were crossed with mice in which exon 2 and 3 of the 




 mice (B), excision of 




 (A) mice were used as wild type 
controls.  
BMDM of PHD2-/- mice have already been successfully tested for their PHD2 knock out on 
both RNA and protein level (Güntsch et al., in revision).  
3.14 PHD2-/- macrophages show a different inflammatory response after induction of 
myocardial infarction 
Macrophages lacking PHD2 expression show an impairment of essential macrophage 
functions such as phagocytosis and migration in vitro (Güntsch et al., in revision). In order to 
validate whether this phenomenon would influence the inflammatory reaction caused by 
ischemia, PHD2-/- mice and their wild type littermates underwent a myocardial infarction 
caused by the permanent ligation of the left anterior descending coronary artery (hereafter 
called MI). The following inflammatory response was measured via flow cytometric analysis 
of heart tissue lysates. Characteristic surface markers were used in order to identify different 
myeloid populations such as leukocytes (CD11b+), macrophages (F4/80+ CD11b+) and 
neutrophils (Ly6G+ CD11b+). Inflammatory cells were studied 3 and 7 days after surgery. In 
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order to verify that the induced inflammation was not an artefact from the surgery itself, 
sham-operated mice were included as controls. 
Analysis of leukocyte and neutrophil populations after induction of a myocardial infarction did 
not show any differences between wild type and PHD2-/- mice (Figures 28A and B), neither 3 
days nor 7 days after surgery. In general, inflammation was higher at day 3 than at day 7, 
indicating that the inflammatory reaction is already regressing at the latter time point. Sham-
operated mice showed significantly lower levels of CD11b-positive and Ly6G CD11b-positive 
cells than the ones undergoing MI, which indicates that the inflammatory reaction is mostly 
caused by the infarction itself.  
 
Figure 28: Leukocyte and neutrophil infiltration after myocardial infarction (MI) in PHD2
-/-
 mice. 
(A) Leukocytes were quantified as CD11b-positive cells within tissue lysates of hearts after sham-
operation or induction of MI. (B) Neutrophils were quantified as a subpopulation of leukocytes as Ly6G 
CD11b-positive cells. Groups include n=5 mice for day 3 and day 7 sham, n=5 for wild type day 3 and 
day 7 MI and n=7 for PHD2
-/-
 day 3 and 7 MI. Bars show mean ± SEM. 
The amount of macrophages within the tissue after MI induction differed significantly 
between wild type and PHD2-/- mice (Figure 29A). At day 3 after surgery, wild type mice 
showed higher numbers of macrophages compared to PHD2-/- mice. At day 7 however, the 
picture changed with PHD2-/- mice showing significantly higher levels of macrophages 
compared to wild type mice. This indicates a delayed onset of macrophage infiltration into the 
tissue, which could potentially be explained by the migratory defect of PHD2-/- macrophages, 
which has been observed in vitro. 
In addition, the macrophage population was further analyzed towards their polarization into a 
pro-inflammatory M1 (Figure 25B) or anti-inflammatory M2 phenotype (Figure 29C). CD86 
(M1-marker) and CD206 (M2-marker) expressions were analyzed via the mean fluorescence 
intensity within the macrophage population. No difference in expression of both M1 and M2-
marker was observed between wild type and PHD2-/- macrophages at both time points, 






Figure 29: Macrophage infiltration after induction of MI in PHD2
-/-
 mice. (A) Macrophages were 
identified as F4/80 CD11b-positive cells within tissue lysates of hearts after MI or sham operation. The 
polarization of macrophages was studied by analyzing the surface expression of CD86 (M1-marker, B) 
and CD206 (M2-marker, C) within the macrophage population as geometric mean fluorescence 
intensity. Groups include n=5 mice for day 3 and day 7 sham, n=5 for wild type day 3 and day 7 MI 
and n=7 for PHD2
-/-
 day 3 and 7 MI. Graphs show mean ± SEM with * p<0.05, ** p<0.01.  
In summary, macrophage invasion and clearance from the heart after surgical induction of a 
myocardial infarction was less in PHD2-/- at day 3 but more at day 7, indicating a delayed 
onset of macrophage invasion. This could potentially be caused by a migratory defect of 
PHD2-/- macrophages, which has already been observed in vitro. The overall leukocyte 
population, as well as the neutrophil population did not show any significant changes 
between wild type and PHD2-/- mice, indicating that this is a macrophage-specific effect. Also, 
macrophage polarization was unchanged, which goes in line with in vitro findings in BMDM, 
where M1- and M2-markers were not differentially expressed on RNA level (Güntsch et al., in 
revision). 
3.15 PHD2-/- mice have a worse heart function 6 days after MI surgery 
In order to analyze whether PHD2-/- mice had an altered clinical outcome after the induction 
of a myocardial infarction, echocardiography was performed 1 day before and 6 days after 
surgery. Heart function was analyzed via measuring the fractional area shortening, a 





fraction, which describes the fraction of the blood which is pumped out of the heart during 
each heartbeat (Figure 30).  
In contrast to sham mice, both wild type and PHD2-/- mice showed a significant decrease of 
heart function after MI-surgery. Between both groups, PHD2-/- mice showed an even worse 
heart function than wild type mice. This could be caused by the prolonged inflammatory 
response of PHD2-/- macrophages. 
 
Figure 30: Heart function in PHD2
-/-
 mice after myocardial infarction. (A) Fractional area 
shortening analyzed before and 6 days after surgery in sham operated and MI mice. Groups include 
n=9 wild type sham mice, n=8 PHD2
-/-
 sham mice, n=15 wild type MI mice and n=16 PHD2
-/-
 MI mice. 
Graphs display mean ± SEM with * p<0.05, *** p<0.001.  
 
3.16 Initial infarction size after MI surgery is similar between wild type and PHD2-/- mice 
In a publication including global haplodeficient PHD2+/- mice, the authors argue that 
preconditioning of the blood vessels via increased arteriogenesis at baseline would improve 
the outcome of PHD2+/- mice not only after hind limb ischemia, but also after myocardial 
infarction (Takeda et al., 2011). The infarction size was therefore analyzed 6 hrs after 
myocardial infarction (Figure 31) in order to test, whether there would be a difference visible 
between wild type and PHD2-/- mice already at this early time point.  
Hearts were isolated and areas that were still perfused were stained with Evan´s blue. Area 
which was not stained blue was defined as area at risk (AAR, Figure 31A). Hearts were then 
stained with TTC, which stained the still viable areas of the AAR in red. The area which could 
neither be stained by Evan´s blue nor by TTC was defined as area of necrosis (AON).  
Analysis of the ratio between AAR and AON did not show any significant changes between 
wild type and PHD2-/- mice (Figure 31B). Also, the total area at risk was weighed and found 
not to be significantly different between wild type and PHD2-/- mice (Figure 31D), indicating 





arteriogenic preconditioning, but has to arise later than 6 hrs after surgery, possibly by 
immunologically regulated processes like the invasion and clearance of macrophages. 
 
Figure 31: Initial infarction size in wild type and PHD2
-/-
 mice. Infarction size was measured 6 hrs 
after surgery via staining the hearts with Evan´s blue and TTC.  (A) The perfused area of the heart 
was stained with Evan´s blue. The area not stained in blue was defined as area at risk (AAR). Viable 
cells within the AAR could be stained in red by TTC, while the area which stayed pale was defined as 
area of necrosis (AON). (B) The fraction of the AON was analyzed within the AAR. (C) Analysis was 
based on images from infarcted hearts of wild type and PHD2
-/-
 mice. (D) The total weight of AAR was 
determined between wild type and PHD2
-/-
 mice. In total groups include 4 wild type and 5 PHD2
-/-
 








Ischemic diseases such as peripheral artery disease or myocardial infarction trigger an 
inflammatory response, which can influence the extent of tissue damage. Major players in 
this sterile inflammation are macrophages and neutrophils which are recruited to the 
ischemic site and clear up necrotic tissue cells. The invasion of many oxygen-consuming 
cells however aggravates the hypoxic situation, to which both immune cells and tissue-
resident cells have to adapt to. The adaptation to hypoxia is mediated by HIF-1 and HIF-2, 
which induce the expression of over 100 target genes identified so far. The regulation of HIF 
is mediated on protein level, via the prolyl-4-hydroxylation of conserved prolines within HIFα 
subunits, which leads to ubiquitination by pVHL and subsequent proteasomal degradation. 
The prolyl-4-hydroxylation is mediated via PHD 1-3, which need molecular O2 as cofactor. 
Therefore, HIFα degradation can only take place when enough oxygen is present. In 
hypoxia, however, HIFα is stabilized. PHD1-3 thus act as the oxygen sensors of the cell. 
PHD1-3 have been described to have overlapping as well as distinct functions. Both PHD2 
and PHD3 have been shown to regulate functions of myeloid cells. PHD3 deficiency in vitro 
protects macrophages from apoptosis. In the context of abdominal sepsis, PHD3 deficiency 
has been described to activate macrophages towards a pro-inflammatory phenotype. PHD2 
deficiency in macrophages leads to a metabolic shift towards anaerobic glycolysis in vitro, 
which is linked to decreased migration and phagocytotic capacity. 
Deficiency for the cellular oxygen sensors PHD2 and 3 in macrophages has not yet been 
studied in depth in the context of ischemic diseases. The aim of this thesis was therefore to 
elucidate the role of PHD2 and 3 in macrophages upon the induction of sterile inflammation 
in mouse models of ischemia.  
4.1 Macrophage infiltration into the ischemic muscle is blunted in PHD3-/- mice 
I studied macrophage and neutrophil infiltration and clearance in the ischemic muscle after 
hind limb ischemia via flow cytometry. Both populations have been shown to have an 
efficient PHD3 knock out in the applied mouse model.  
In neutrophils, PHD3 deficiency did not affect the time course of infiltration and clearance 
compared to wild type. This result was surprising, because an earlier study identified PHD3 
as potent regulator of neutrophil lifespan (Walmsley et al., 2011). Walmsley and colleagues 
found that PHD3-/- neutrophils died faster in hypoxia than wild type neutrophils. In an in vivo 
model of acute lung injury, this led to reduced neutrophil counts 18 hours after injury. 
Assuming that the inflamed site in the hind limb should also be hypoxic due to the surgical 





at day 1 and 3 after surgery. This was however not observed, which might be due to the 
different inflammatory triggers. Although the associated receptors and pathways in sterile 
and pathogen-associated inflammation can be overlapping, there are also pathways that are 
unique to each setting and could account for the observed differences. Moreover, in a model 
of abdominal sepsis, neutrophil infiltration into the lung was unchanged 8 hrs after LPS 
injection in a global PHD3 knock out (Kiss et al., 2012).  
PHD3-/- macrophages showed a blunted inflammatory response after induction of hind limb 
ischemia. While initial recruitment until day 3 was still comparable to wild type macrophages, 
both at day 4 and 5 after surgery, PHD3-/- macrophages were present in significantly lower 
numbers compared to wild type macrophages. In a previous study, PHD3 deficiency was 
linked to higher inflammation and tissue infiltration of macrophages in a model of abdominal 
sepsis (Kiss et al., 2012). This finding was obtained in a global PHD3 knock out mouse, but 
transplantation of bone marrow from PHD3-deficient mice to wild type mice could mimic the 
effect, which suggests the involvement of a bone marrow-derived cell type. The reason for 
the striking difference in macrophage behavior observed by Kiss and colleagues compared 
to the data presented in this thesis could lie in the different trigger for inflammation. While the 
intraperitoneal injection with LPS presents a nonsterile inflammatory trigger, induction of 
hypoxia by ligation of an artery might trigger a different response. The versatility of the 
macrophage-response might allow for a differential role of PHD3, dependent on the stimulus. 
In human monocyte-derived macrophages and different human tissue samples, PHD3 
seems to be a marker of pro-inflammatory macrophages (Escribese et al., 2012) which is in 
contrast to the findings by Kiss and colleagues in murine samples. However, the authors did 
not study to which extent the expression of PHD3 could regulate macrophage polarization 
into pro-inflammatory macrophages or whether PHD3 had an important role in mediating pro- 
or anti-inflammatory functions of macrophages. 
In the present study, both at day 4 and 5 after surgery, macrophages displayed higher levels 
of the anti-inflammatory marker CD206 while a marker for pro-inflammatory macrophages 
(CD86) was not significantly changed. Anti-inflammatory macrophages are important for the 
resolution of inflammation and stimulate angiogenesis via secretion of VEGF. The 
upregulation of CD206 in PHD3-/- macrophages could be indicative of an earlier initiation of 
wound-healing processes. In cell culture, PHD3-deficient BMDM did not show a difference in 
polarization under basal conditions or after stimulation with IFN-ɣ and LPS or with IL-4 
(Swain et al., 2014). Culturing of cells at 20% O2 as well as the artificial stimulation can 
however not mimic the in vivo conditions of macrophages in the ischemic tissue, which could 





In summary, the present study provides evidence for a so far not described anti-inflammatory 
effect of a myeloid-specific knock out of PHD3, which is mediated via a blunted macrophage 
response. The observed differences to already published work of other groups and our own 
group could be related to differences in the experimental setups that were used. 
4.2 Reperfusion recovery and development of necrotic toes are unaffected in PHD3-/- 
mice 
Macrophages can express pro-angiogenic factors such as VEGF to stimulate the formation 
of new blood vessels (Berse et al., 1992; Sunderkotter et al., 1994). Furthermore, a positive 
effect of macrophages on arteriogenesis has been shown (Arras et al., 1998; Takeda et al., 
2011). Angiogenic and arteriogenic effects both contribute to the recovery of perfusion in 
models of hind limb ischemia. In order to evaluate the outcome of myeloid-specific PHD3-
deficiency on reperfusion after hind limb ischemia surgery, laser Doppler images of paws 
were analyzed before and until 28 days after surgery. No difference could be observed at 
any of the time points between wild type and PHD3-/- mice.  
In the context of hind limb ischemia, PHD3-deficiency has so far only been studied in global 
murine knock out or knock down models (Loinard et al., 2009; Rishi et al., 2015). While both 
studies observed a positive effect of decreased PHD3 levels for the angiogenic response, 
none could pinpoint this effect to a certain cell population or reveal the underlying 
mechanism. Loinard and colleagues observed an increased macrophage infiltration of the 
tissue in mice with a PHD3 knock down, which was linked to a better reperfusion and a 
higher capillary density. Whether the increased macrophage recruitment was an effect 
primarily mediated by the PHD3-deficient macrophages, or if other PHD3-deficient tissue-
resident cells attracted more macrophages to the site of ischemia remains unclear.  
My findings do not support the idea that PHD3-deficiency in myeloid cells has a positive 
effect on angiogenesis or arteriogenesis. The data obtained from laser Doppler images in 
this study was further secured by quantifying angiogenesis on tissue sections 3 and 28 days 
after surgery, which did not show any difference between wild type and PHD3-deficient mice. 
Also, the development of necrotic toes, which is an indicator for how well the hind paws are 
perfused, was unchanged between wild type and PHD3-/- mice. 
4.3 Fibrosis is decreased in PHD3-/- mice which did not reflect in an improved motor 
function 
Macrophages are key players in the restoration of organ homeostasis in the end phase of a 
sterile inflammation. In order to test, whether PHD3-deficiency in macrophages had any 
effect on fibrosis, mice underwent hind limb ischemia surgery. Gastrocnemicus muscles were 
excised 28 days after surgery and sections were stained for collagen-fibers using the dye 





could be observed compared to wild type mice, indicating a better wound healing in PHD3-/- 
mice.  
In a myeloid PHD3-knock out, no data on the development of fibrosis after induction of hind 
limb ischemia have been published yet. In a global PHD3 knock out, Rishi and colleagues 
observed less fibrosis 28 days after surgery, together with a better perfusion and higher 
capillary density in PHD3-deficient mice (Rishi et al., 2015). The decrease in fibrosis could be 
a secondary effect of the better perfusion recovery after hind limb ischemia. In my study 
however, perfusion was unchanged between wild type and PHD3-/- mice after hind limb 
ischemia surgery. The decreased fibrosis observed by me might have resulted from less 
damage in the early phase of inflammation due to less macrophage infiltration.  
The ability to move the ischemic leg is an important clinical parameter which is affected by 
perfusion as well as fibrosis. I examined whether the myeloid-specific PHD3 knock out mice 
differed in their ability to move the ischemic leg both in resting conditions and by measuring 
the maximum speed they could run.  
To study motor function in resting conditions, the motor score grading system used by Rishi 
and colleagues was applied (Rishi et al., 2015). No difference could be observed between 
wild type and PHD3-/- mice. Interestingly, motor function recovered to baseline within 7 days 
after surgery in my study, while Rishi and colleagues only saw complete recovery at day 14 
for the PHD3 global knock out, and at day 28 for the wild type mice. This difference occurred, 
although mouse strain, sex, age and the general surgery technique were the same. This 
effect could have been caused by the inbreeding of the mice or by specific differences in the 
surgery technique which were not apparent from the brief description given by the authors in 
their publication. 
The maximum running ability of mice was also tested using a RotaRod system. No difference 
could be observed between wild type and PHD3-/- mice. However, the drop in motor function 
after surgery was very mild, which indicates that mice of both genotypes could effectively 
compensate their impairment. Also, mouse behavior had a strong influence on the outcome 
of this experiment with “fast” and “slow learners” in both wild type and PHD3-/- groups which 
accounts for the high standard deviation. 
My findings suggest that the myeloid-specific PHD3 knock out results in a decrease in 
fibrosis, which did however not reflect in an improved motor function in these mice. This 
might be caused by the in general rather small drop in motor function after surgery in wild 





4.4 Apoptosis and migration are unaltered in PHD3-/- macrophages 
As described in a previous chapter, equal amounts of macrophages are present in the 
muscle tissue at day 3 after hind limb ischemia surgery when comparing wild type and PHD3-
/- mice. At day 4 and 5, macrophage numbers are significantly lower in PHD3-/- compared to 
wild type mice. In order to find out by which mechanism this happened, apoptosis and 
migration of PHD3-/- macrophages were analyzed. 
PHD3 has already been reported to be a potent regulator of apoptosis in various cell types 
(Lipscomb et al., 1999; Walmsley et al., 2011; Xie et al., 2015). In BMDM, PHD3-deficiency 
had an anti-apoptotic effect when cells were cultivated under stress conditions such as 
starvation or treatment with S-nitroso-N-acetyl penicillamine (SNAP) or stauroporine (Swain 
et al., 2014). In this thesis, apoptosis was analyzed both in wild type and PHD3-/- 
macrophages isolated from the gastrocnemicus muscle 4 days after hind limb ischemia 
surgery. No difference was observed between wild type and PHD3-/- macrophages in the 
abundance of apoptotic or dead cells. Swain and colleagues could only observe an anti-
apoptotic phenotype in PHD3-/- BMDM after applying distinct triggers such as starvation or 
pro-apoptotic stimuli. These stimuli might not necessarily be present in the ischemic muscle, 
however, which might explain the difference to the findings of this thesis. Furthermore, the 
applied experimental setups of in vitro differentiated macrophages and macrophages isolated 
from an in vivo inflammatory reaction are not directly comparable. 
PHD3 has been shown to mediate non-muscle actin hydroxylation and thereby impair the 
migration of HeLa cells (Luo et al., 2014). Furthermore, Kiss and colleagues could observe 
an enhanced migration in PHD3-deficient peritoneal macrophages (Kiss et al., 2012). I 
wanted to investigate whether a change in migration would be a possible explanation for the 
decreased macrophage numbers 4 and 5 days after surgery. I therefore performed single cell 
migration assays on wild type and PHD3-/- peritoneal macrophages and BMDM. No 
difference could be observed neither in basal conditions nor upon stimulation with MDA-
MB231-conditioned medium. In contrast to Kiss and colleagues, the peritoneal macrophages 
I isolated were not elicited with thioglycollate, a substance which by itself already activates 
macrophages. The divergent migration results could therefore potentially be caused by this 
difference. 
To conclude, my data do not suggest an involvement of an altered apoptosis rate or 
migratory capacity in the blunted PHD3-/- macrophage response after hind limb ischemia. The 
observed differences to the already published data might have resulted from the different 





4.5 RNA sequencing of macrophages sorted from gastrocnemicus muscles 5 days 
after surgery revealed 10 differentially regulated genes 
In order to characterize the PHD3-deficient macrophages present in the ischemic muscle 
even further, RNA expression was analyzed via RNA sequencing of macrophages sorted 
from the ischemic muscle 5 days after hind limb ischemia surgery. In total, 10 differentially 
regulated genes could be identified based on a p-value below 0.05 and a minimum log fold 
change of ±1.  
The fact that only 10 genes were identified might be caused by a high variability due to 
several influencing parameters. The high variability in part derives from the surgery, which 
can never be reproduced exactly the same. Mice were age and sex-matched, but they 
originated from different litters. Another influencing factor is the digestion efficiency, which 
could have led to more variance, especially because the samples were isolated at 4 different 
days. 
In total, 3 so far uncharacterized transcripts are significantly up- or downregulated in the RNA 
sequencing. Especially GM22567, which shows a -2.76 log2 fold downregulation and 
therefore the highest regulation of all 10 regulated genes, presents an interesting target for a 
future project to identify its function related to PHD3 in macrophages.  
The PHD3-dependent regulation of miR-511, Cyp2s1 and Rbm4 in PHD3-/- cells has not yet 
been described before. All of these genes have previously been linked to inflammatory 
processes (Brudecki et al., 2013; Fromel et al., 2013; Puimege et al., 2015). A transcriptome 
screen performed by Swain and colleagues studying PHD3-/- and wild type BMDM could not 
identify these genes as differentially regulated (Swain et al., 2014). The screen described by 
Swain and colleagues applied different culturing conditions such as 48 hrs of normoxia or 
hypoxia as well as 48 hrs of starvation to the BMDMs. The differences between 
differentiating and culturing macrophages in vitro and the isolation of in vivo macrophages 
might account for the discrepancy between the findings of Swain and colleagues and the 
ones presented in this thesis. The genes Cyp2s1, miR-511 and Rbm4 were subsequently 
tested again for their differential regulation in an independent set of FACS-sorted 
macrophages via qRT-PCR, which could confirm the differential regulation for miR-511 and 
Cyp2s1, but not for Rbm4.  
PHD3 was not significantly downregulated in PHD3-/- macrophages in the RNA sequencing. 
Although PHD3 levels were lower in PHD3-/- macrophages compared to wild type, PHD3 was 
in general expressed at very low levels. The expression level is characterized by the RPKM-
value of each gene, which is calculated as the amount of transcripts which could be mapped 
to the respective gene in relation to the total amount of transcripts and the length of the 





and was therefore not considered in the statistical analysis. A possible reason for the low 
expression of PHD3 could lie in the isolation process of the macrophages. PHD3 is 
expressed at low levels in normoxia, but heavily induced in hypoxia in BMDMs (Swain et al., 
2014). During the isolation of macrophages from the ischemic hind limb muscle the 
reoxygenation of the cells upon exposure to the atmospheric pO2 could not be prevented. 
This reoxygenation could have led to a rapid downregulation of PHD3 mRNA transcription.  
The RNA sequencing did not reveal a differential expression of HIF-target genes in PHD3-/- 
macrophages compared to wild type. In line with this, HIF-1α and HIF-2α protein levels were 
not differentially regulated in PHD3-/- BMDM, nor was the expression of typical HIF-target 
genes such as phosphofructokinase (Pfk)-1, GLUT-1 or PDK-1 (Swain et al., 2014).  The 
reason for the lack of HIF-1α stabilization in PHD3-/- BMDM could lie in the different 
importance of the three PHD isoforms for HIF degradation. Among the three PHDs, PHD2 
has been demonstrated to be the main regulator of HIFα stability, at least in normoxia 
(Appelhoff et al., 2004; Berra et al., 2003). Silencing of PHD2 consequently leads to 
normoxic stabilization of HIFα and increased transcription of HIF-target genes (Berra et al., 
2003). For PHD1 and 3 knock outs however, normoxic stabilization of HIFα and subsequent 
upregulation of its target genes is commonly not observed (Berra et al., 2003; Swain et al., 
2014).  
The RNA sequencing did not show any differential expression of typical pro- or anti-
inflammatory cytokines such as TNF-α, IL-1β, IL-6 or IL-10. This is in line with studies 
performed in PHD3-/- BMDM, which could also not detect any differences in expression or 
secretion of pro-inflammatory cytokines (Swain et al., 2014). However, macrophages isolated 
from the hind limb showed a higher surface expression of the mannose receptor and M2-
marker CD206 on day 4 and 5 after surgery. In the RNA sequencing, CD206, encoded by 
Mrc1, was slightly but not significantly upregulated. The higher surface expression of CD206 
in PHD3-/- macrophages 4 and 5 days after hind limb ischemia surgery could be due to a 
regulation on protein level. CD206 is important for phagocytosis during which is gets 
internalized. A regulation of CD206 via protein degradation rates as well as via protein 
localization has been implicated (Fiani et al., 1998) which could possibly explain why no 
change in RNA expression was detected in the RNA sequencing though CD206 levels were 
higher on PHD3-/- macrophages. 
4.6 miR-511 expression and TNF-R1 levels in PHD3-/- macrophages 
TNF-R1, a receptor for TNF-α, is a target of miR-511 (Puimege et al., 2015). TNF-R1 
downregulation caused by a 2-fold miR-511 upregulation led to less inflammation in a model 
of TNF-α-induced shock. The RNA sequencing identified miR-511 as upregulated in PHD3-/- 





muscle 4 days after hind limb ischemia surgery was studied in order to see whether this 
could be a potential mechanism, by which the blunted inflammatory response of 
macrophages is mediated. However, only a mild and not significant downregulation of TNF-
R1 was observed. TNF-R2, which has not been described to be targeted by miR-511 showed 
a similar mild downregulation. This could indicate a non-miR-511-related effect to be the 
cause for slightly decreased TNF-R1 levels. These data suggest that upregulation of miR-
511 does not influence the anti-inflammatory macrophage behavior by regulating TNF-R1 
levels.  
To identify a different mechanism by which miR-511 influences macrophage behavior, 
mimicking the differential regulation of miR-511 in PHD3-/- macrophages in vitro would 
present a suitable model. However, even in different culture conditions such as hypoxia, 
normoxia, starvation as well as addition of glucocorticoids to stimulate miR-511 expression, 
no difference in mi-R511 expression could be observed between wild type and PHD3-/- 
macrophages. This impeded further studies on the effect of miR-511 in cell culture.  
4.7 Cyp2s1 expression is downregulated in PHD3-/- BMDM which coincides with 
increased phagocytotic capacity and increased Prostaglandin E2 secretion 
In line with the RNA sequencing results, the expression of Cyp2s1 was downregulated in 
PHD3-/- BMDM, at least in hypoxia combined with starvation. Cyp2s1 had not been described 
to be differentially regulated in a transcriptome screen performed on PHD3-/- BMDM (Swain 
et al., 2014). This might be caused by the fact that cells cultivated in hypoxia in starvation 
medium were not included in that screen.  
Cyp2s1 has been described to identify pro-inflammatory macrophages both in vitro and in 
vivo (Fromel et al., 2013). In vitro, stimulation of human monocyte-derived macrophages with 
LPS and IFN-ɣ induced Cyp2s1 expression. In the present study, a set of 3 pro-inflammatory 
cytokines was tested to see if the decreased levels of Cyp2s1 in PHD3-/- macrophages 
correlated with the expression of these cytokines. No correlation between Cyp2s1 and 
cytokine expression patterns was observed, indicating that Cyp2s1 is rather a target of 
inflammatory regulation than an active part in its mediation. 
Cyp2s1 is an epoxygenase which has been described to metabolize PGG2 and PGH2 to 12-
HHT (Fromel et al., 2013). PGH2 is synthesized from arachidonic acids by the action of 
Cyclooxygenase-1 (COX-1) and 2 via the intermediate product PGG2. PGH2 also serves as 
a substrate for PGE2 synthesis via the PGE2 synthases (reviewed by (Kalinski, 2012)). 
PGE2 is a potent pro- and anti-inflammatory mediator, which in the early inflammatory phase 
mediates attraction and activation of neutrophils, but has also been described to enhance 
M2-polarization of macrophages and interfere with NLRP3 inflammasome activation in sterile 





These diverse roles are mediated by 4 different prostaglandin E2-receptors (EP) 1-4, which 
require different PGE2 concentrations for their activation (reviewed by (Kalinski, 2012)). The 
most commonly proposed regulation mechanism of PGE2 synthesis is via the expression of 
COX-1 and -2, which produce PGE2´s precursors PGH2 and G2. I here hypothesize that the 
accumulation of these precursors due to an attenuated metabolism to 12-HHT could also 
lead to an increased PGE2 synthesis. Given that the levels of Cyp2s1 are significantly lower 
in PHD3-/- macrophages compared to wild type, more PGG2 and PGH2 would be disposable 
as substrate for PGE2 synthesis. Indeed, increased levels of PGE2 were observed in PHD3-/- 
BMDM cultivated for 24 hrs in hypoxia in starvation medium. PGE2 has been shown to 
negatively affect phagocytosis in rat and murine alveolar macrophages and murine peritoneal 
macrophages (Aronoff et al., 2004; Hubbard et al., 2010; Konopski et al., 1993). However, IL-
10 which is highly induced by PGE2 can also stimulate phagocytosis (Lingnau et al., 2007). 
Downregulation of Cyp2s1 by siRNA furthermore leads to increased phagocytosis in 
monocytes (Fromel et al., 2013). In this study, phagocytosis was increased in PHD3-/- BMDM 
upon starvation. Treating wild type cells with enough PGE2 to reach the levels secreted by 
PHD3-/- BMDM led to an increase in phagocytosis to the level of untreated PHD3-/- BMDM. 
This finding indicates that the differential PGE2 secretion might be responsible for the 
increased phagocytosis in PHD3-/- BMDM. This is in line with data suggesting that low doses 
of PGE2 can have stimulatory effects on phagocytosis while higher doses inhibit 
phagocytosis in macrophages (Razin et al., 1978; Razin and Globerson, 1979). The 
mechanism for this is so far unclear, but could involve the PGE2 receptors EP2 and EP3. 
While EP2 responds only to high doses of PGE2 and increases cAMP levels in the cell, EP3 
is activated already with lower doses of PGE2 and decreases cAMP levels (reviewed by 
(Kalinski, 2012)). In line with this, cAMP has been shown to reduce phagocytosis (Rossi et 
al., 1998).  
Further studies are needed to investigate whether increased PGE2 levels are responsible for 
the anti-inflammatory phenotype of PHD3-/- macrophages in vivo. 
4.8 PHD2-/- macrophages show a delayed inflammatory response after induction of 
myocardial infarction as well as a worse heart function compared to wild type 
PHD2-deficient macrophages have been shown to display a metabolic shift towards 
anaerobic glycolysis which is linked to a decreased migration and phagocytotic capacity 
(Guentsch et al., in revision). To evaluate whether this effect would influence macrophage 
behavior in vivo, myeloid-specific PHD2 knock out mice underwent myocardial infarction 
which induced an inflammatory response caused by ischemia. At day 3 after surgery, PHD2-/- 
macrophages were less abundant than wild type macrophages in isolated hearts. At day 7 





macrophages, which were already decreasing in number compared to day 3. This indicates a 
delayed response of the PHD2-/- macrophages, which could be caused by a delay of 
migration into the tissue combined with the incapability to phagocytose apoptotic neutrophils 
and thereby resolve the inflammation. In a model of angiotensin II-induced hypertension, 
myeloid-specific PHD2-/- mice displayed less macrophage infiltration into the heart which was 
linked to less fibrosis (Ikeda et al., 2013). In vitro, the authors observed a migration defect in 
peritoneal macrophages, which is in line with the migration data obtained from PHD2-/- 
BMDM (Guentsch et al., in revision).  
Although a glycolytic metabolism has been linked to M1-polarization in macrophages, flow 
cytometric analysis of the M1-marker CD86 did not show differences neither at day 3 or 7 
between wild type and PHD2-/- macrophages (Galvan-Pena and O'Neill, 2014). Also, no 
polarization into M2-macrophages could be observed, analyzed by the expression of CD206 
on the cell surface of macrophages. This is in line with data from PHD2-/- BMDM, where no 
enhanced polarization into M1 or M2-macrophages was observed in basal conditions or upon 
stimulation with IL-4 or IFN-ɣ and LPS (Guentsch et al., in revision). Furthermore, two other 
reports did not observe a M2-polarization in PHD2-/- macrophages while M1-markers were 
slightly downregulated in myeloid-specific PHD2 knock out mice in models of hypertension 
and tumor formation (Ikeda et al., 2013; Mamlouk et al., 2014). In contrast to that, PHD2 
haplodeficiency seems to be able to induce M2-like macrophages which exert a pro-
arteriogenic effect on smooth muscle cells (Takeda et al., 2011). This effect seems to be 
strictly limited to heterozygous PHD2 knock out mice, as it could not be reproduced in 
homozygous PHD2 knock out mice (Takeda et al., 2011). 
The heart function of wild type and PHD2-/- mice was significantly worse after induction of MI. 
This might have been caused by the delayed inflammation observed via flow cytometry. 
Further studies are needed to dissect whether the worse heart function was caused by a 
migration defect or by an impaired phagocytotic capacity. Interestingly, the migration defect, 
also observed in a model of increased afterload in myeloid-specific PHD2-/- where it had 
beneficial effects (Ikeda et al., 2013), seems to have a detrimental effect in the setting of 
myocardial infarction. This could be due to the different course of disease. While myocardial 
infarction induces a sudden injury which leads to cell necrosis and requires a prompt answer 
by the immune system, angiotensin II-treatment induces rather a chronic injury leading to 
cardiac remodeling. In the latter setting, macrophage infiltration might do more harm than 
good.  
4.9 Therapeutic inhibition of PHDs - implications for myeloid cells  
Lack of oxygen is not the only factor which can inhibit PHDs. PHDs can be inhibited by 





by inhibiting the enzyme´s catalytic site. Iron chelators such as Co2Cl or desferrioxamine can 
decrease the availability of Fe(II) and thereby inhibit PHDs. The depletion of available Fe(II) 
by iron chelators is however unsuitable for clinical use due to systemic side effects. 
Furthermore, substances like DMOG, which is a 2-OG analogue, can inhibit PHD activity. 
DMOG is however rather unspecific and also inhibits other 2-OG-dependent dioxygenases, 
which makes it likewise unsuitable for clinical use.  
In terms of specificity, advances have been made within the past decade. Substances such 
as Roxadustat (FG-4592, Fibrogen) or 2-(1-chloro-4-hydroxyisoquinoline-3-carboxamido) 
acetate (ICA) are 2-OG analogues which specifically target PHDs and do not interfere with 
other 2-OG-dependent dioxygenases. However, the differences between the 2-OG binding 
sites of PHD1, 2 and 3 isoforms are so little, that so far, no PHD isoform-specific inhibitor 
could be developed. Several of the PHD-specific inhibitors are in clinical trials at the moment. 
Roxadustat for example, is currently in a phase III clinical trial for the treatment of anemia in 
patients with chronic kidney disease (NTC01750190). A clinical trial with PAD patients using 
a similar compound called GSK1278863 could not show an amelioration in muscle 
performance, neither when administering a single dose nor small doses given over a period 
of 14 days (Olson et al., 2014). However, this might be due to dosage problems, as muscle 
biopsies could not show elevated HIF-stabilization. In myeloid cells, PHD inhibitors such as 
TM6008 exert anti-inflammatory effects in murine macrophages (Takeda et al., 2009). 
Clinical trials have not yet studied the effect of PHD-inhibitors in the setting of inflammation. 
The data presented in this thesis rather suggest that inhibition of PHD2 might have an 
unfavorable outcome due to decreased migration and phagocytosis capacity, which prolongs 
the course of inflammation. In contrast to that, PHD3-inhibition might present an advantage 
for wound healing. PHD-isoform specific inhibitors would be needed to dissect wanted from 
unwanted effects when treating patients undergoing a sterile inflammation caused by 
ischemia. 
4.10 Conclusion and outlook 
To conclude, this study presents novel findings regarding the function of PHD2 and 3 for 
macrophages in the setting of sterile inflammation.  
In myeloid-specific PHD3 knock out mice, a blunted inflammatory response of the 
macrophages was observed upon the induction of hind limb ischemia. This finding was in 
contrast to earlier studies, which observed a more pronounced macrophage-infiltration in 
PHD3-/- mice upon induction of a non-sterile inflammation (Kiss et al., 2012). PHD3-/- 
macrophages however did not induce an angiogenic response, nor did myeloid PHD3-
deficiency alter the reperfusion recovery after induction of hind limb ischemia by a different 





indicating that the altered inflammatory response had a beneficial effect for the restoration of 
tissue homeostasis.  
While differences in apoptosis or migration were apparently not the trigger for the decreased 
inflammatory response of PHD3-/- macrophages, a RNA sequencing of macrophages sorted 
from hind limb muscles 5 days after hind limb ischemia identified 10 differentially regulated 
genes. Out of those, Cyp2s1, which is downregulated in PHD3-/- macrophages, presents a 
putative mediator of the differential inflammatory response between wild type and PHD3-/- 
macrophages. As Cyp2s1 metabolizes the substrates for PGE2-production, I analyzed 
whether the decreased expression of Cyp2s1 in PHD3-/- BMDM correlated with increased 
PGE2 secretion. This was indeed the case. Since PGE2 can induce anti-inflammatory effects 
on macrophages, this is a putative mechanism for mediating the decreased levels of 
macrophages 4 and 5 days after surgery, which also showed an increased M2-marker 
expression.  
PGE2 secretion was upregulated in PHD3-/- BMDM upon starvation in hypoxia. It is however 
unclear whether the increased PGE2 secretion is in fact due to Cyp2s1 downregulation. 
Transfection of wild type BMDMs with Cyp2s1 siRNA or its inhibition by CYP inhibitors 
liarozole or miconazole should be studied to see whether PGE2 secretion can be increased 
by these mechanisms.  Furthermore, secretion of PGE2 by macrophages isolated from the 
ischemic muscle could be studied. This would include the sorting of macrophages and their 
subsequent culturing. If that was indeed the case, it would be interesting to study myeloid-
specific Cyp2s1 knock out mice to see whether the reduced inflammatory response after hind 
limb ischemia is indeed due to Cyp2s1 levels. The role of 12-HHT, the product of Cyp2s1, 
should also be studied in further depth. In keratinocytes, 12-HHT stimulates migration via 
leukotriene B4 receptor type 2 (BLT2), which leads to enhanced wound healing in mouse 
models (Liu et al., 2014). In macrophages, no function has been described yet. Furthermore, 
it would be interesting to study miR-511 and its potential targets more in depth.  
In a myeloid-specific PHD2-knock out, a delayed inflammatory response of the macrophages 
was observed in a model of myocardial infarction. This was linked to a worse heart function 
of PHD2-/- mice. These findings could be explained by in vitro data on PHD2-/- BMDM, which 
show a delayed migration as well as a decreased phagocytotic capacity. These effects were 
linked to a metabolic shift towards anaerobic glycolysis. 
Further studies are needed to test whether the macrophages in vivo display a metabolic 
phenotype. For this, macrophages could be sorted from heart muscles after LAD surgery for 
RNA sequencing. In PHD2-/- BMDM, several metabolic enzymes such as PDK-1 are 
transcriptionally regulated. It would be interesting to see whether PHD2-/- macrophages 





macrophages with dichloroacetate (DCA), which inhibits PDK-1 and thereby stimulates 
oxidative phosphorylation, could partly rescue their phenotype. It would be interesting to 
know if the in vivo phenotype could be rescued in a similar manner. 
In addition, a direct comparison of the effects of myeloid-specific PHD2 and 3 knock outs 
would be desirable. For this, it would be interesting to study both in the same model of sterile 
inflammation. Preliminary data from PHD2-/- mice after hind limb ischemia did not show any 
striking phenotype in relation to perfusion recovery or in the inflammatory response 
compared to wild type mice. It would therefore be interesting to investigate the inflammatory 
response of PHD3-/- macrophages in a model of myocardial infarction. Therapeutic 
intervention is so far only possible by using Pan-PHD inhibitors.  In a murine model of 
myocardial infarction, the administration of 2-(1-chloro-4-hydroxyisoquinoline-3-carboxamido) 
acetate (ICA) has already been tested. The application of ICA led to a robust HIF-1α and -2α 
stabilization for at least 24 hrs and to a decrease in infarction size and better heart function 
when administered 1 and 5 hrs after induction of MI (Vogler et al., 2015). If administered for 
longer, PHD-inhibitors might interfere with the inflammatory response mediated by 
macrophages. This would however, based on the divergent roles of the different PHDs 
observed in this thesis, not necessarily lead to a beneficial effect on the initial inflammatory 
response. As the inflammatory response is a determinant for tissue restoration and organ 
function on the long term, patients might not benefit from the administration of a pan-PHD 
inhibitor in the inflammatory phase. The presented data therefore suggests a helpful role for 
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